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ABSTRACT

MOLECULAR STUDIES OF
T LYMPHOCYTES FROM BOVINE LEUKEMIA VIRUS
INFECTED CATTLE

by

Diana Lynn Williams

Highly specific monoclonal antibodies and
raicrofluorimetry were used to determine the absolute number
of B and T lymphocytes in the peripheral blood of bovine
leukemia virus (BLV) infected cattle.

The peripheral blood

lymphocyte populations from BLV-infected cattle

were

elevated when compared to BLV-negative animals.

The

increase in the lymphocyte population in the aleukemic (AL)
animals was

due to an increase in T

lymphocytes.

In

animals the

increase was due mainly to an increase of B

lymphocytes

but also to an increase of T lymphocytes.

thePL

The PL animals showed a significantly higher number of
surface immunoglobulin positive cells (slg'*') than did the
animals.

AL

The majority of these cells contained surface IgM

and had large quantities of this marker on their cell
surfaces.

One PL animal (632) had a very high lymphocyte

count and contained lymphocytes that appeared to stain with
markers for both bovine B and T lymphocytes.

xvi

Bovine T lymphocytes were purified from the peripheral
blood Df BLV~infected, AL cattle using icnmuno-affinity
depletion technique ("panning") with anti-bovine
immunoglobulin-coated flasks.

Large yields of highly

purified T lymphocyte preparations (95-10054 T lymphocytes
and 0-3?. contamination with B lymphocytes) were obtained by
the use of this technique.
The BLV provirus was found in the DNA of peripheral
blood lymphocytes and 3 of A purified T lymphocyte
preparations from AL animals using hybridization analysis
uith radiolabeled BLV-DNA as a probe.

Hybridization

analysis also confirmed that the B lymphocyte is the major
target of BLV infection.
The blastogernic response of lymphocytes from PL and AL
animals to selected phytomitogens appeared to be normal when
compared to the responses of BLV-negative,
animals.

clinically normal

The sera from both AL and PL animals contained a

heat-stable* camitogenic blastogenesis-augmenting factor.

xvii

CHAPTER is

INTRODUCTION

Enzootic bovine leukosis (EBL) is a neoplasm of
lymphatic tissue in the bovine species (B).

The etiologic

agent is bovine leukemia virus (BLV) (10B)* an exogenous*
leukomogenic virus of the family Retroviridae.

This virus

may induce two clinical manifestations of disease either a
benign proliferation of lymphocytes referred to as
persistent lymphocytosis (PL) or the development of
malignant lymphosarcoma (LS)

(46).

The majority of animals

infected with BLV do not show any clinical signs of disease
(88).

These animals are referred to as inapparent carriers

or as being aleukemic (AL).

Some of these AL animals (25 X)

will develop PL* and a small percentage (0.1 to 1 X) will
develop LS (108).
Studies have been conducted to investigate the
relationship between the PL and LS stages of EBL (46*51)*
but* very few studies have been done to investigate the
relationship between the AL and PL stages of EBL. This may
be very important since the switch from the AL to PL stage
may be one of the primary steps in the progression of the
disease to the tumor phase.

Over 75X of LS cattle have a

chronic PL phase which precedes tumor development

(108).

A target cell of BLV-infection in the cow has been
reported to be the B lymphocyte (121). The majority of
lymphocytes found in the peripheral blood of PL cattle have
surface markers typical of B lymphocytes (110*156)* and a

1

percentage of these cells have been shown to exhibit viral
antigens on their cell surfaces (72).

A recent report

suggested that some tumors consisted of cells that not only
bear surface antigens of T lymphocyte lineage but also
contain the BLV provirus <9D).

The role of bovine T

lymphocytes in the progression of EBL has not been
investigated.
Reports in the current literature have focused on the
antigenic relatedness of BLV and the human T lymphotropic
viruses HTLV I & II.

These viruses are associated with

human T cell leukemias (116*128).

The T lymphocyte appears

to be the target of both of these viral agents.

Therefore*

if T lymphocytes are found to be target cells of BLV and/or
important in the progression of EBL* not only will this
information aid in the better understanding of bovine
leukosis*

it may also help to establish an animal model to

study human viral induced leukemia.

I. A.

STATEMENT OF RESEARCH PROBLEM

Bovine T Lymphocytes from AL and PL cattle are the
subject of these studies.

Definitive studies on these cells

in EBL have not been conducted mainly because purified
preparations and specific markers for these cells have not
been available.

Monoclonal antibodies directed toward the

surface antigens of bovine cells of the T lymphocyte lineage
have recently been produced and characterized (90)* but

purification techniques have not been perfected to give good
yields of highly purified lymphocyte subpopulations.

In

order to determine whether T lymphocytes may serve as
targets for BLV it is nessecary to have large quantities of
purified T lymphocytes for DNA hybridization analysis.
Further studies on T lymphocytes may help to define
how the AL to PL shift is mediated.

Information on the

absolute number of T lymphocytes in the peripheral blood of
AL and PL cattle may indicate that there is a modulation of
this cell population in these animals.
occur as a result of BLV— infection.

This modulation may

Information on the,

functional ability of T lymphocytes from AL and PL cattle to
respond to selected phytomitogens may indicate a modulation
of the functional ability of these cells (T-helper and Tsuppressor).

The uncontrolled proliferation of

undifferientiated B lymphocytes in the PL animal may be the
result of a lack of or enhancement of a particular T cell
subset function.

Therefore* studies on bovine T lymphocytes

are needed to attempt to define the role if any of these
cells in the AL and PL phases of EBL.

I. B.

OBJECTIVES

The different chapters of this dissertation describe
specific experiments that were employed to accomplish the
following objectives!

4

1,

To determine the numbers of bovine T and B
lymphocytes from AL and PL cattle using
monoclonal antibodies that distinguish these
lymphocytes.

2-

To purify T lymphocytes from bovine peripheral
blood mononuclear cells (PBMC) of cattle using
immuno-affinity depletion "panning".

3.

To assess the presence of BLV provirus in
purified T lymphocytes and PBMC of AL cattle and
the PBMC of PL cattle using DNA hybridization
analysis.

4.

To evaluate and compare the responses of
lymphocytes in AL and PL cattle to selected
phytomitogens using the lymphocyte
blastogenesis assay.

The aim of these investigations is to acquire a better
understanding of the role that bovine T lymphocytes play in
the maintainance of the AL and

PL stages of EBL.

The

results from these investigations are presented as
individual chapters.

Some of these have been submitted for

publication to different Journals.
indicated belou:

They are entitled as

"Enumeration of T and B lymphocytes in aleukemic and
persistent lymphocytotic cattle using monoclonal
antibodies that distinguish these cells.
Submitted for publication to the "Journal of the
National Cancer Institute".

Co-authored by U. Davis

and G. Amborski.

■Purification of bovine T lymphocytes from peripheral
blood mononuclear cells using an immuno-affinity
depletion technique ("panning").

Accepted for

publication in "Veterinary Immunology and
Immunopathology". Co-authored by J. Lo and
G. Amborski.

"Assessment of the presence of bovine leukemia
provirus in the DNA of purified bovine T
lymphocytes of BLV-infected* aleukemic cattle."
Manuscript in preparation for publication to
"Cancer Research".

Co—authored by G. Amborski.

"Evaluation of the responses of lymphocytes of
aleukemic and persistent lymphocytotic cattle to
selected phytomitogens".

Manuscript in preparation

for submission to the "American Journal of
Veterinary Research".
and G. Amborski.

Co-authored by 0. Barta

CHAPTER IIs

A-

LITERATURE REVIEW:

ENZOOTIC BOVINE LEUKOSIS

Enzootic bovine leukosis (EBL) is a lymphoproliferative
disease of the bovine species (6>.

The etiologic agent is

bovine leukemia virus (BLV), an exogenous leukemogenic virus
of the family Retroviridae (108,75).

The presence of this

virus appears to be a prerequisite for tumor development,
but, it is not by itself sufficient to cause the disease
(75).

The virus may induce either inapparent, aleukemic

(AL) infections or two clinical manifestations of the
disease,

persistent lymphocytosis (PL) or malignant

lymphosarcoma (LS)

(46).

II. A. 1. Aleukemic State
Once infected with BLV, cattle show no signs of overt
viremia,

however, they elicit a strong and persistent

humoral response to BLV structural proteins (49).

Most

infected cattle <75%) have no clinical signs of disease.
These animals are inapparent carriers or AL cattle.
gain and milk production is unaltered (88).

Weight

Lymphocyte

counts remain in the normal range between 2.5 to 7.5 x
ID3 /mm3 of whole blood (2).

There has been very little

information reported about the AL state of BLV— infection.
II. A. 2.

Persistent Lymphocytotic State

Approximately 30% of BLV infected cattle develop PL
(108).

This stage of BLV— infection is a nonmalignant
6

hematological disorder characterized by an increase of
circulating peripheral blood lymphocytes (PBL)

(> 7.5 x

lO^/mm3 of whole blood) for over a period of 3 months (2).
Weight gain and milk production appear to be unaltered (88).
In most of the PL animals tested*

it appears that the

increase in the number of PBL is attributed to an increase
in B lymphocytes (110*156).

An increase in T lymphocytes of

some animals has also been reported (142).

The PL state is

generally a chronic condition that may or may not lead to
the tumor stage of EBL (108*51).

The PL phase precedes the

tumor phase (LS) in approximately 75’
/, of the cases (51).
12. A. 3. Enzootic Bovine Lymphosarcoma
The adult form of bovine lymphosarcoma or EBL is most
prevalent in dairy cattle herds and typically occurs in
animals older than 2 years of age.

It is a chronic disease*

evolving over extended periods (1—8 years)* with tumors
developing in only a small number of infected animals (0.1—
1%) (108).

The majority of cattle affected by EBL are those

from 5 to 8 years of age.

Tumors observed in EBL cases are

always of lymphoid origin and may invade mammary glands*
subcutaneous tissues* abdominal muscles*

diaphragm* heart*

respiratory tract and spinal cord (19).

Tumors are

inconsistent in location and tumGrization is usually
asymmetrical

(53*17).

As tumors grow* they mechanically

impair normal function of organs* and the ultimate stage is
complete destruction of the original organ structure.

Any

lymph node may be affected* but the pelvic lymph nodes are

most often involved.

Lymphosarcoma induced by BLV

eventually leads to either death of the affected animal or
condemnation of the carcass at slaughter.
U.

A. 4. Geographic Distribution of EBL

The first cases of EBL were reported in Germany in 1B7B
and in the United States in 1897 (9,8).
world wide distribution (19).

The disease now has

In some parts of the world

such as Switzerland and other parts of Europe, eradication
programs are in progress (19).

In these areas the number of

cases of EBL is steadily decreasing.

Some sections of the

United States are endemic areas for EBL.

One such area is

Louisiana where many herds contain 75-100% BLV positive
reactors (71).
II. A. 5. Diagnosis of BLV Infection
The viral etiology of EBL was shown in 1969 (106).
Serological identification of reactors became possible in
1972 (45).

Diagnostic techniques presently available for

the detection of BLV reactors are virus neutralization (61),
complement fixation (140,31), agar gel immunodiffusion
(AGID) (33,34), enzyme-linked immunoabsorbent assay (ELISA)
(80), radioimmunoassay (RIA)

(125,89), and the syncytia

induction and syncytia induction neutralization assays using
bovine fetal spleen cells as indicator cells (40,62).
AGID is the most commonly used diagnostic tool.

The

This assay

detects antibodies to the major envelope and core proteins
of BLV in the serum of infected cattle.

Various serologic

diagnostic tests have demonstrated that BLV antibodies are

detectable in > 90’
A of LS and PL animals (19).
II. A. 6. Transmission of BLV
Studies conducted in mant) laboratories indicate that
contact transmission is the principal method by which BLV is
spread (122*AS).
vivo (42,3),

Since BLV particles are seldom produced in

it is likely that in most cases BLV infection

in cattle is the result of the transfer of infected
lymphocytes rather than viral particles. The transfer of as
few as 1 x ID4* blood lymphocytes from infected to non—
infected animals results in virus transmission (20).
Penetration of the skin appears tc be the mode of entry of
the virus,

therefore*

infection can be easily spread through

multiple use of needles* ear tagging devices* dehorning and
castration equipment (154*160).

Transmission studies using

potential insect and tick vectors have been conducted
(21*114*130).

These investigations indicate that BLV may be

spread by stable flies (Stomoxys calcitrans)* horn flies
(Haematobia irritans)* horse flies (Tabanidae) (21*114)* and
some species of ticks (Boophilus microplus) (130).
Another possible means of BLV spread is in utero
transmission. The incidence of transmission of BLV from
infected dam to fetus is very low (46* 123).

Usually less

than 155i of BLV-infected cows give birth to infected calves
(123).

Colostrum and milk are potential sources of

infection (50*119).

Both contain BLV-infected lymphocytes*

but the amount is minimal when compared to tnat of the blood
(109).

Usually antibody present in the colostrum of
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infected cows is adequate for protecting calves until about
a months of age <50, 49).

Pasteurization of infected milk

totally destroys BLV (5).
Vertical transmission xn the gametes has never been
observed (109).

In Sweden* transmission of BLV has occurred

through the use of a BLV— contaminated babesiosis vaccine
<19).

All the above observations confirm that natural

spread of BLV occurs mainly through the horizontal route.

II. B.

BLV Infection in Other Animal Species

Natural cases of viral-induced lymphomas in sheep are
rare.

The virus isolated from these cases appear

indistinguishable from BLV (19).

Sheep have been

experimentally infected with either cell— free virus or BLVinfected lymphocytes from infected cattle.
not occur in sheep.

Typical PL does

Lymphosarcoma usually occurs quite

rapidly after infection (1-3 years) and at a much higher
frequency than in cattle (19).

Anatomopathological lesions

are comparable for tumors of sheep and cattle.

BLV

sequences are present in tumor tissue but absent from normal
tissue.

Recent evidence seems to indicate that, unlike BLV-

induced tumor cells in cattle, tumor cells in sheep are of T
lymphocyte origin (67).

BLV-infected sheep have antibodies

to structural proteins of the virus.
been demonstrated in sheep (19).

No viremia has ever

BLV-induced lymphosarcoma

of sheep does not seem to be naturally transmitted from
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animal to animal.
BLV-induced lymphosarcoma has been demonstrated in only
one other animals species.

After numerous attempts to

induce LS in goats with BLV experimentally*
reported (115).

Lymphoid tumors appeared in many organs 6

years postinfection.
chimpanzees*

one case was

Many other animal species such as

pigs* domestic rabbits* cats, dogs, deer, rats*

and guinea pigs have been experimentally infected with BLV*
but in none of these species were viremia or pathological
disorder observed (97*153).

The only species which 'remained

antibody positive was the chimpanzee (153).

BLV infection

in humans has never been documented (6*153*97).

II. C. SPORADIC BOVINE LEUKOSIS

EBL induced by BLV should be distinguished from
sporadic bovine leukosis (SBL) which includes the Juvenile*
skin* and thymic forms of the disease (1).
associated with BLV infection.

Only EBL is

The SBL forms occur at

random* having no proven association with an infectious
etiology.

The possibility exists that other bovine

retroviruses may be associated with this condition* although
this has not been thoroughly investigated.

A transient

lymphocytosis may be detected in some SBL cases.

The target

cell of SBL appears to be the lymphocyte stem cell because
tumors consist of cells of both T and B lymphocytes lineage
(19).

The calf or Juvenile form generally occurs in calves
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less than 6 months of age* however*
animals.

it can occur in older

Tumor cells can be found in lymph nodes*

spleen and bone marrow.

liver*

In contrast the thymic form,

typically restricted to the region of the thymus* the calf
form typically occurs in young animals (6 to 3D months of
age) and appears mainly in beef herds rather than in dairy
herds (43).

The skin form is extremely rare* and the only

form of lymphosarcoma that is not fatal.

Lesions of this

form may regress but a generalized lymphadenopathy may occur
(19).

II. D. OTHER BOVINE LYMPHOTROPHIC RETROVIRUSES

Studies on EBL have resulted in the isolation of two
other bovine retroviruses*

bovine syncytial virus (BSV) and

bovine visna-like virus (BVV) which also produce syncytia in
cell culture (54*96).
However,

Their relationship to EBL is unclear.

neither agent is considered to be a significant

factor in the cause of EBL (149*150).
II. D. 1. Bovine Syncytial Virus
BSV is a bovine lymphotrophic retrovirus that was
originally isolated from buffy coat cells* spleen*

lymph

nodes and milk of lymphosarcomatous and normal cattle (150).
The target cell(s) of this virus is not known nor is the
effect of infection on susceptible animals. This viral agent
induces syncytia formation in monolayer cultures of bovine
fetal spleen cells and has been morphologically
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characterized as a foamy virus (96*150).

BSV was

originally suspected of being the etiologic agent of EBL
(96).

Subsequent studies demonstrated that only 22% of LS

animals had detectable levels of serum antibodies to BSV*
whereas* over 90% of LS animals had detectable antibodies to
BLV (148,19).

Observations of experimentally infected

calves and immunodiffusion tests of sera from normal and
lymphosarcomatous cattle as well as cattle from multiple
incidence lymphosarcoma herds have not provided evidence for
a direct etiologic involvement of BSV in either the PL or LS
stages of EBL (148).
II. D. 2

Bovine Visna—Like Virus

A syncytia-inducing virus (BVV) isolated from a cow
with PL was found to be similar in structure to maedi,
visna, and progressive pneumonia viruses of sheep (149).
Calves inoculated with virus isolated from this PL cow
developed a mild nonpersistent lymphocytosis and
subcutaneous lymphatic nodules.

The relationship of BVV to

the induction of PL is unclear, but it does not appear that
this viral agent is a significant factor in the development
of PL or LS (149).

II. E. LYMPHOCYTES IN ENZOOTIC BOVINE LEUKOSIS

Lymphocytes in man and animals are composed of two
subpopulations: thymus—derived (T) lymphocytes, which are
involved in cell—mediated immunity and bursal—equivalent

(B)
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lymphocytes*

primarily involved in humoral immunity.

An

understanding of the recognition and effector functions of
these lymphocytes in disease processes is clearly dependent
on the ability to enumerate and separate these cells for
functional analysis.

Various techniques

have been used for

the isolation and enumeration of T and B lymphocytes in the
bovine species and have been applied to BLV— infected
animals.
11. E. 1 Lymphocyte Isolation Procedures
Bovine peripheral blood mononuclear cells (PBMC) have
been isolated routinely using a density gradient of ficoll
(146).

This technique gives highly purified populations of

mononuclear cells with an average of 2% polymorphonuclear
leukocytes.

Numerous other techniques have been utilized to

isolate lymphocyte subpopulations.

Nylon wool columns have

been used to fractionate B and T lymphocytes (121) and yield
highly purified T (nonadherent) and B (adherent) lymphocyte
populations (95%)*

but recoveries are very low (2 to 20%).

Antibody— complement immunolysis has been used to selectively
deplete B lymphocytes from PBMC and hence enrichs the T
lymphocyte population (146).

This technique also gives low

yields of purified T lymphocytes.

Bovine serum albumin

gradients have been used to isolate subpopulations of bovine
lymphocytes on the basis of their bouyant density.

The

purity and yield of these preparations are also low (73).
The techniques currently used to isolate bovine
lymphocyte subpopulations do not give large quantities of
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highly purified T or B lymphocytes.

Recently, an immuno-

affinity depletion technique using immunoglobulin-coated
surfaces has been used to isolate and purify murine
peripheral blood T and B lymphocytes (92, 95). This
technique has not been applied to purification of large
quantities of bovine lymphocyte subpopulations.
II. E. 2. B Lymphocyte Markers
The B lymphocytes have 3 generally recognized cell
surface receptors:
(37.36),

(2)

(1) surface membrane immunoglobulin (slg)

receptor for the Fc portion of immunoglobulin

(38.36) and (3) the receptor for complement (29).

These

markers have been used to distinguish bovine B lymphocytes.
The slg— bearing lymphocytes (slg'*') have been detected
by an immunofluorescence antibody technique which uses
fluorescein—conjugated F(ab')2 fragments of rabbit antibovine IgG (heavy and light chain specific)
recently, monoclonal anti— IgM (127,110,90).

(Rablg—FITC) and
Rablg-FITC is

specific for cells which contain slg (IgA, IgM, IgG) on
their surface since this marker is directed against the
neavy chains of all the immunoglobulin classes.

The anti—

IgM is specific for cells which contain surface IgM because
this antibody is directed towards the heavy chain of IgM (u
chain).

Isotype specific lymphocyte surface immunoglobulins

have not been as well studied in the cow as in certain other
species.

The isotypes on slg* bovine peripheral blood

lymphocytes appear to be mainly IgM and IgA (85, 55).

It

was found that anti—bovine IgM is a highly specific marker
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for bovine peripheral blood B ly m p h o c y t e s <55* 90).
Detection of the Fc receptor on the surface of bovine B
lymphocytes has been accomplished using an
immunofluorescence technique* erythrocyte—antibody
complement rosetting (EAC rosette) technique and slg
staining (B5,142*110*156).

The complement receptor has also

been used to detect B lymphocytes (10).

The use of these

techniques has led to a wide range of values for bovine B
lymphocytes in the PBMC of normal cattle. Many of these
techniques are very cumbersome to perform.
II. E. 3. Bovine T Lymphocyte Markers
Markers which have been used for enumeration of bovine
T lymphocytes include:
cells (sRBC)

(127*142)*

(PNAR) (147)*

(1) receptors for sheep red blood
(2) receptors for peanut agglutinin

(3) alpha-naphthy1 acetate esterase (ANAE)

positive granules (71)* and (4) T lymphocyte surface
antigens (B4).
The frequency of lymphocytes which contain receptors
for sRBC has been measured by the use of a sheep erythrocyte
rosetting technique (E-rosette)

(73*127*142).

Peanut

agglutinin receptor—positive cells (PNAR*) have been
detected by a direct fluorescence technique using
fluorescein-conjugated peanut agglutinin.

This technique

has been reported to be a very specific means of enumerating
□ovine T lymphocytes (147* 55).

Recently* with the use of

monoclonal antibodies (MAb) directed towards T lymphocyte
surface markers*

it was found that PNAR can be found not
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anly on T lymphocytes but also on other leukocytes (90).
ANAE staining has been used as a cytochemical marker to
enumerate bovine T lymphocytes (71), and the frequency of
bovine T lymphocytes has been measured by direct
immunofluorescence using anti— bovine T lymphocyte serum
(ATS)

(04).
Many of the above markers and detection techniques have

been used to enumerate T and B lymphocytes in normal and
BLV-infected animals.

The use of the above markers for

enumeration of bovine T lymphocytes has led to great
variation in the numbers of these cells in the PBMC of
normal as well as BLV-infected animals.

Recently, MAb

specific for the sRBC receptor on the surface of bovine T
lymphocytes have been prepared, characterized and used to
enumerate the frequency of T lymphocytes in the PBMC of
normal cattle (90).
II. E. 4. Frequency of T and B Lymphocytes in Enzootic
Bovine Leukosis
Some of the above techniques for B and T lymphocyte
enumeration have been used to study the frequency of these
cells in PBMC from cattle with AL, PL and LS.

Very little

information is available on the lymphocytes of AL animals.
One study of 8 cattle in the AL stage showed that lymphocyte
counts averaged between 3.4 x lO3 to 7.5 x 103 /mm3of whole
blood and between 12 to 50% of these cells were slg'*' (72).
An increase in slg^ lymphocytes in the PL phase of the
disease has been observed (110, 85, 72).

The values

averaged 2B% for BLV-negative <normal) and 63% far PL cattle
(110).

One report indicated that PL cows had 3.85 times

more slg*lymphocytes than did normal cows (85).

When EAC

rosetting was used to enumerate the frequency of £
lymphocytes in the PBMC of PL animals* values of 10% to 20%
for normal cattle* and 55% to 81% for PL animals were
observed (72).

Lymphocyte counts in the PL group ranged

from 11.0 x 103 to 22 x ID3 /mm73 of whole blood* and there
was a significant strong correlation between the percentages
of cells bearing the B lymphocyte markers and the absolute
lymphocyte counts (72).
Tumor development correlates with a drastic
modification of lymphocytosis (rapid increase or decrease of
the total lymphocyte count) and the presence in the
peripheral blood of lymphoblasts and lymphocytes with
altered morphological and karyotypic characteriseics (104).
Many animals with LS have lower percentages of circulating
slg + cells and lymphoid cells from tumorous lymph nodes of
these animals have a higher percentage of slg bearing cells
than normal lymph nodes (142).
Studies using E-rosette formation as a marker for
bovine T lymphocytes indicated that between 12.5 to 26% of
PBMC of normal cattle* 3.5 to 26.5% of PBL from BLV-infected
cattle (AL or PL status unknown) and 0.5 to 50% of PBL from
LS animals formed E-rosettes (142).

This study also

reported that in tho lymph nodes of BLV-negative animals*
8.5 to 30.5% of lymphoid cells formed E—rosettes.

E—rosette
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positive cells from lymph nodes of BLV-infected animals
ranged from 7 to 43.5%.

Lymph node cells from LS animals

had 10% or fewer positive cells (142).

Investigations using

(ANAE) staining to identify T lymphocytes in cattle
concluded that an average of 47.7% ANAE positive cells were
present in the PBMC of normal cattle* and 20.5%
present in the PBMC of PL cattle
concluded that in the PBMC of PL

were

(71). Therefore, this study
there was a decrease in the

number of T lymphocytes.
Studies were conducted using an indirect
immunofluorescent antibody technique with rabbit anti— bovine
thymocyte serum (ATS) to detect T lymphocytes in the PBMC of
BLV-negative,
(84).

PL and LS cattle and tumor cells of LS cattle

The frequency of T lymphocytes in the PBMC of BLV-

negative animals ranged from 55 to 80%,
to 45%, and LS animals from 5 to

PL animals from 4

38%. The percentage of T

cells found in tumors ranged from 2 to

30%.

As described above, the use of such a variety of
techniques for T and B lymphocyte enumeration has led to a
wide range of values for these cells in both normal and BLVinfected cattle.

The MAbs recognizing bovine T lymphocytes

have not yet been used to assess the absolute numbers of T
lymphocytes in BLV-infected cattle.
II. E. 5.

BLV Target Cells

Since tumors present in EBL are neoplasms of the
lymphoid system, cells of the lymphocyte lineage were the
first candidates to be suspected as BLV-preferred targets.
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This bias shown to be correct by demonstration of BLV
production in vitro from cultures of lymphocytes from BLVinfected cattle (10B* 120).

The target cell of BLV

infection has been reported to be the B lymphocyte as
evidenced by the presence of slg on the majority of tumor
cells and BLV-infected lymphocytes in the peripheral blood
of PL and LS cattle (72* 120).

However* a recent report

which investigated the phenotype of lymphoblastoid cell
lines derived from two cases of LS indicates that BLV may
also infect cells of the T lymphocyte lineage (91).
It appears that BLV is present in a subpopulation of B
lymphocytes of PL cattle (73).

A nylon wool separation

procedure was used to fractionate the B and non—B
populations of peripheral blood of BLV-infected cattle.

It

was discovered that the capacity to produce C-type particles
resided with the B lymphocytes (119).

This was demonstrated

by the use of transmission electron microscopy and the
induction of syncytia in bovine fetal spleen cells
(120*121*73).

From these studies*

it was concluded that 397.

of the B lymphocytes produced BLV particles.

This implies

that BLV may be associated with a certain subpopulation of B
lymphocytes.
Isolation of a subpopulation of BLV-infected
lymphocytes from AL and PL animals was accomplished by the
use of density gradients of bovine serum albumin (B5A) (73).
The B lymphocytes were reportedly separated into two
distinct subpopulations* one which produced BLV and the
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second which did not produce BLV* but underwent spontaneous
blastogenesis when cultured in vitro <73).

The BLV-

nonproducer accounts for most of the cell—count increase in
PL as assayed by the uptake of tritiated thymidine which
measures DNA synthesis.

It is not known if the lymphocytes

which incorporate '~*H thymidine* but do not produce BLV*
contain the BLV provirus in a repressed state.

No further

characterization of either of these two cell populations has
been reported.
II. E. 6.

Immune Responses to BLV Infection

Humoral response to BLV antiyens has been observed
shortly after infection (49). The presence of antibodies
directed against the major glycoprotein of the viral
envelope (gp51) and internal viral core protein <p 24) is
detectable shortly after experimental BLV infection (49).
The anti—gp51 antibodies are consistently formed at a higher
titer than anti— p 24 antibodies and display virus
neutralizing activity and a strong cytolytic effect on BLV—
producing cells in the presence of rabbit complement (47).
Recently* a study was conducted to assess the humoral
and cellular responses in calves experimentally infected
with BLV (107).

The results showed that there was an

increase in the number of B lymphocytes* a decrease in the
number of T lymphocytes and reduced levels of IgM in the
sera of BLV infected calves.

These findings seemed to

indicate that the immune system of these calves was affected
by the viral infection and a state of immune—suppression was
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induced (107).
Responses of lymphocytes from normal) AL* PL and LS
cattle to phytomitogens have been evaluated using the
lymphocyte blastogenesis assay (111*

112* 157* 132).

This

assay has been used to determine the functional ability of
both T and B lymphocytes to respond to mitogenic stimuli.
The T lymphocytes of normal cattle were found to be
stimulated with both phytohemagglutinin (PHA)
Concanavalin A (ConA)

(111)

132) and

(157). The T and B lymphocyte

populations responded to pokeweed mitogen (PWM) (111)132).
The mitogenic activity of PHA and PWM was studied on the
PBMC from cows with PL, and it was found that when using
stimulation indices)

the degree of stimulation was markedly

less for PBMC of PL cattle than for normal cows. Lymphocytes
from cows with PL cultured without phytomitogens
incorporated 5 times more tridiated thymidine than did
lymphocytes from normal cows (112).

It has been reported

that this spontaneous blastogenesis is BLV—antigen driven
because it can be inhibited by serum containing BLV
antibodies but not by normal serum (143).
The response of cultured PBMC from cattle affected with
EBL to the mitogenic activity of ConA has been determined
(157).

It was found that the stimulatory effect of ConA was

significantly decreased in lymphocytes from LS cattle in}
comparison to lymphocytes from normal animals.
The sera from cows with LS have been shown to inhibit
the blastogenesis of normal lymphocytes (6B). This
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suppressive activity was not observed in sera from animals
that were infected with BLV but did not have LS.

These

results indicated that sera from l.S animals contained
suppressive factor(s).

No further characterization of this

serum factor(s) was reported.
The above studies indicated that the functional ability
of T lymphocytes from AL animals to proliferate in response
to mitogens appeared to be intact* but the functional
ability of T lymphocytes in the PL and LS stages of EBL
appeared to be suppressed.

It is known that the percentage

of T lymphocytes in the peripheral blood is significantly
decreased in the PL animal.

Therefore*

the reported

reduction in the response of the T cells in these animals
may be due at least in part to the low number of these cells
present in the lymphocyte blastogenesis assays.
Suppression of natural cytotoxic activity of
lymphocytes from PL and LS animals has been observed (164).
It was demonstrated that the cytotoxic activity of PBMC was
closely related to the stage of the disease.

The activity

of PBMC from cattle with PL and LS was decreased markedly
when compared to that of normal or AL animals (164).

II. F. MOLECULAR STUDIES OF BLV

IX. F. 1. Bovine Leukemia Virus
The putative etiological agent of EBL is BLV.

This

virus has been identified as an RNA virus of the family
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Retroviridae and is characterized as a C-type oncornavirus
(158,75). Since the original discovery of BLV in the
supernatant fluids of short—tern* cultures of PL lymphocytes*
long-term cultures producing BLV have been obtained.

These

include cell lines derived from explanted tumor tissues or
various epithelioid and fibroblastoid cell lines infected
with BLV after co-cultivation with BLV-infected bovine
lymphoid cells (151*98*44).

Most of the information on the

structure and biosynthesis of BLV components has been
obtained from the fetal lamb kidney-BLV-producing cell line
(FLK-BLV)

(152).

The BLV virus has a sedimentation coefficient of 600S to
70QS with a buoyant density of 1.15 to 1.18 g/ml in sucrose
and 1.12 g/ml in metrizamide solutions (39*59*74*75).

The

diameter of mature BLV particles ranges between 68 and 125
nm (22*23*15B).

Particles contain a central electron— dense

nucleoid with a diameter of 40 to 90 nm* and it appears that
the nucleocapsid is icosahedral
a 70S RNA.

(155).

The virion contains

Denaturation of this virion RNA yields poly <A>-

containing subunits that sediment at 38S and are found to be
of molecular weight 2.95 x 10** daltons (ca.8.8 kb) in sodium
dodecyl sulfate polyacrylamide gels (57*25).
II. F. 2.

BLV Proteins.

The internal structural protein* p2* was the first
recognized BLV protein.

It has been purified and

extensively characterized (58*106*32).

This protein has

been partially sequenced and appears to share the
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aminoterminal praline and carboxyterminal leucine of the p30
of all mammalian retroviruses.

However*

it has been found

that BLV p24 is antigenically distinct from the major core
protein of most other retroviruses.

Nucleic acid and amino

acid sequence homology has been found between BLV p24 and
the major p£4 core protein of HTLV I (118*128).
The major phosphoprotein of BLV* pl5* is a slightly
basic protein that exists in two populations of molecules
(70).

One is linked to the lipid bilayer of the viral

membrane* and the other is linked to viral RNA.
basic protein of BLV is pi2.

Another

This protein has been shown to

be in close proximity to viral RNA in BLV particles (144).
Zt has been reported that there is amino acid homology
between BLV pl2 and human T— cell Leukemia virus (HTLV I) pl2
(118*128).

The other basic protein plO is able to bind to

single-stranded DNA (93) Nature BLV particles also contain a RNA-dependent DNApolymerase (reverse transcriptase) of an approximate
molecular weight of 70*000 dal tons (41).

This enzyme is

strictly dependent on RNA and all four deoxyribonucleoside
triphosphates and*

irrespective of template-primer used*

displays a strong preference for Hg’*"*" over Mn*'*' (59*58*75).
The major envelope glycoproteins of BLV are gp51
gp60) and gp3D.

(or

These proteins are found associated as a

1*1 complex linked by disulfide bonds in viral particles
isolated under nonreducing conditions (18).

It appears that

these proteins are both derived from a precursor protein

gPr72"‘r"’
' and appear as a tetramer with two g p ^ molecules
buried in the membrane structure of the virus* while the two
gp51 molecules protrude outside (56*99).

The overall

structure resembles that of an inununoglobulin molecule.

The

gt*51 appears to function in the attachment of the virus to
the target cell.

Monoclonal antibodies to BLV gp51 have

been obtained in the mouse using either nondisrupted BLV
particles or purified gp51 as immunogens (16,15).

Antigenic

determinants on gp51 were shown to be involved in
determining both virus infectivity of and syncytia formation
by BLV—producing cells as well as functioning as a target
for antibody-mediated complement-dependent cytotoxicity
(15).

It appears that the carbohydrate residues on gp51 are

very important virus neutralization epitopes (15).
From recent reports*

it appears that the BLV genome

like that of the HTLV's (HTLV I,HTLV II, and HTLV III) may
produce another as yet uncharacterized protein referred to
as a trans—acting protein (tat) (138*137,131).

It has been

proposed that this protein is coded for by the long open
reading frame (LOR) region of approximately 16DD nucleotides
3' to the envelope gene.

In HTLV I, it has been proposed

that the HTLV tat protein mediates transcriptional trans
activation of the HTLV long terminal repeat (LTR) (138*137).
The transcriptional initiation signals for these
retroviruses lie within the LTR sequences which flank the
integrated provirus (137).

A 2— kilobase message capable of

encoding such a protein has been detected in BLV-infected
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celIs* but the protein has not been found as an in vitro
translation product of the viral genome (131).
II. F. 3. BLV Genome.
The genome contains the coding capacity for at least
four internal structural proteins (p24* pl5, pl2* plO>,
reverse transcriptase (p70)* and two envelope glycoproteins
<gp51 and gp30> (99*100).

It appears that the BLV gene

order (5' —gag-pol—env—3') is similar to that of other
replication-competent lymphoid leukemia viruses (56).

It is

not clear whether other proteins are encoded by the viral
genome.
Recent studies seem to indicate that the BLV genome
contains ah additional coding region or LOR 3' to the
envelope gene (131).

This gene may code for a tat protein

which may play a vital role in the ability of the virus to
induce transformation (131).
Nucleic acid hybridization experiments run with single
stranded BLV tP-cDNA have shown no homology between BLV and
any other retrovirus with the exception of HTLV I and II
(24*74,75*11B»12B).

Significant homology has been found

with HTLV I (118*128).

Up to 45 7. nucleic acid homology

exists between DNA coding for p24 internal core proteins of
BLV and HTLV I (113).
II. F. 4.

Morphogenesis.

Detailed investigations in various laboratories have
led to the conclusion that BLV has distinct morphogenesis
events from most other retroviruses (22*23).

Some

investigators have shown peculiarities in budding of BLV
viruses when comparing the budding processes of murine and
feline oncornaviruses to that of BLV <2B).

In short-term

lymphocyte cultures* packages of virus particles accumulate
in cytoplasmic bags surrounded by plasma membrane.

BLV

particles are rarely observed to be released from the plasma
membrane into the pericellular spaces or into cytoplasmic
vacuoles (151).

It was suggested that virus particles do not

mature at the cell surface but leave the cell by unusual
routes (22*23). This mechanism of virion maturation may be
responsible for the persistent infections observed with BLV.
Since viral antigens may not be present in large quantities
on the infected cell surfaces* BLV-infected cells may be
protected from lysis mediated by antibody— dependent
cytolysis mechanisms.
II. F. 5.

Viral Persistence

The presence of antibodies directed against the major
glycoprotein of the viral envelope (gp51) and internal viral
core protein (p24) is detectable shortly after experimental
BLV infection (49).

The gp51 antibodies are consistently

formed at a higher titer than p24 antibodies and display
virus neutralizing activity and a strong cytolytic effect on
BLV—producing cells in the presence of rabbit complement
(47).

Antigens do not appear to be expressed at detectable

levels on infected cell surfaces in vivo.

Consequently*

production of virus in the blood plasma appears to be
prevented.

It is not known where virus replication and or
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viral antigen production actually takes place in infected
animals.
The BLV provirus can be demonstrated in the genome of
peripheral blood mononuclear cells (PBMC) and tumor cells
but not nonlymphoid tissues by Southern blot hybridization
analysis of the DNA of these cells (22,73).

There appears

to be host modulation of BLV antigen expression and
efficient control of virus spread.

The BLV proviral genome

can be activated by mitogens (108) or short— term cultivation
(48-72 hours)

(120).

Viral antigens can then be

demonstrated on the surface of infected cells by fluorescent
microscopy techniques (140), and mature virions can be
detected in the .pericellular spaces by transmission electron
microscopy (120).
The control of BLV antigen expression appears to be at
the level of transcription (77).

BLV mRNA transcripts

cannot be detected in noncultivated circulating lymphocytes
or tumor cells from PL or LS animals using solution
hybridization techniques (77,76).

Viral mRNA transcripts

can be detected in these cells using highly sensitive in
situ hybridization techniques.

The amount of viral mRNA

increases with short—term cultivation of these cells (77).
Therefore, there appears to be control of BLV antigen
expression.

This lack of expression of gp51 on the BLV-

infected cell surface could clearly prevent cell lysis by
antibody mediated cytolytic mechanisms and allow for the
expansion of BLV-carrying cells.

The mechanism by which the BLV provirus is
transcriptionally repressed in the lymphocytes of PL and AL
animals is not understood.

A plasma protein has been

reported to be responsible for this repression (63).

This

protein has an approximate molecular weight of 150*000
daltons.

It does not appear to be immunoglobulin or

interferon* but a unique protein contained in the plasma
fraction of BLV— infected bovine blood.

When cel Is are

separated from whole blood using density gradient
centrifugation and washed* this protein is diluted or
completely removed from the cell preparation as assessed by
the increase of BLV p24 production using competitive
radioimmunoassay on cell culture supernatant fluids.
Transcription of the BLV genome can then proceed.
II. E. 6.

Molecular Aspects of BLV— induced
Leu kemogenes is

The exogenous nature of the BLV genome to the DNA of
bovine cells as well as to the DNA of several other
vertebrate species has been well documented (75*30).

It has

also been established that the BLV genetic information
includes no one genes (80).

Liquid hybridization and

Southern blot analysis using a molecularly cloned BLV
proviral—specific probe show that most of the cells of all
BLV— induced tumors contain proviral genetic information
(78).

In individual tumors the site of proviral integration

appears to be mono- or oligoclonal

(78).

However* no

preferential integration site for BLV provirus* such as* in
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close proximity to a cellular one gene sequence has ever
been demonstrated either in tumor cells or PBL of AL or PL
cattle (60*79).

Proviral insertion sites in the

lymphocytes of AL and PL cattle have been observed to be
polyclonal.

The BLV-infected lymphocytes of animals in PL

do not display abnormalities in their chromosomal ploidy as
do tumor lymphocytes (66).
There appears to be a multi-step process for tumor
development. The presence of the BLV provirus appears to be
necessary but* by itself*

insufficient to cause tumors (75).

The role of BLV proviral information in the development
and/or maintenance of the tumor state has been evaluated
(78*76). Cells of BLV— induced tumors contain at least one or
a portion of one provirus.

When deletions occur, they seem

to affect only the 5' half* as the 3' proviral sequences
seem to be conserved.

The conservation of the 3' proviral

sequences may be of functional importance at a particular
stage of disease development.

The tat gene appears to be

located in this portion of the genome (131).

Experiments

indicate that maintenance of the tumor state does not
require a continuous expression of BLV proviral DNA (79).
This may suggest that proviral transcription is important in
a specific stage of EBL. Possibly* the PL stage of EBL is a
manifestation of proviral gene expression.

Gene product(s)

such as the tat protein may induce rapid proliteration of
lymphocytes.

Tumor development may then be a consequence of

chromosomal rearrangements which occur when cells
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proliferate uncontrollably.

This is one mechanism

hypothesized in the tumorgenesis of Burkett's lymphoma (35).
However* restriction enzyme analysis of a panel of ten tumor
DNAs has failed to demonstrate rearrangements of the
cellular homologues of several retroviral one genes
including c-myc, c-myb, c-erbA, c-erbB, c-abl. c-src, crasH » c-fes* and c-sis (BO).

Furthermore, the DNA of most

BLV induced tumors do not induce foci of transformed cells
when transfected into. NIH 3T3 cells.
II. F. 7. Relatedness to Human Lymphotrophic Retroviruses
The importance of studying the parameters involved in
the development of EBL has been emphasized by the close
genetic and antigenic relationship of BLV to some of the
members of the human T lymphotrophic virus family (HTLV)
(128,74,27). This virus family consists of three
retroviruses, HTLV I, II and III (162).

BLV is the closest

known relative of HTLV I and II (94,128,27,133,).

HTLV-I is

the etiologic agent of adult T-cell leukemia (ATL) and HTLVII has been isolated from one patient with hairy T-cell
leukemia (129,162).

Both viruses appear to induce chronic

leukemias and malignant lymphomas in man (165).

These

viruses have a tropism for the helper T lymphocytes
possessing the cell—surface antigen 0KT4 and have the
capacity to transform these cells and like BLV, induce
syncytia formation in vitro (162,68).

HTLV I, II and BLV

appear to have a similar mechanism of transcriptional
activation and may have similar mechanisms of neoplastic
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transformation (137,138,135,131).
A better understanding of the parameters involved in
the development of BLV— induced lymphosarcoma may aid in the
understanding of the mechanismts) of leukemogenesis and
lymphomagenesis with the HTLV viruses.

CHAPTER III:

ENUMERATION OF T AND B LYMPHOCYTES IN

ALEUKEMIC AND PERSISTENT LYMPHOCYTOTIC CATTLE USING
MONOCLONAL ANTIBODIES THAT DISTINGUISH THESE CELLS.

HI.

A. INTRODUCTION

Limited information has been obtained on the immune
response of cattle to bovine leukemia virus (BLV) infection
and the sequence of cellular events that leads to
lymphocytosis and the development of lymphosarcoma.

In

animals which develop a persistent lymphocytosis (PL)* there
appears to be a loss of control of B lymphocyte
proliferation (72*84).
is unclear.

The reason for this lack of control

It may be mediated* at least in parti by a

decrease or increase in T lymphocyte numbers and* possibly*
alteration of the function of these cells.

Since T

lymphocytes help control B lymphocyte proliteration and
differentiation* any alteration in the T lymphocyte
population may have profound effects on the B lymphocyte
population (142).

In a recent report* evidence was

presented which demonstrated that calves experimentally
infected with BLV had an increase in the B lymphocyte
population as determined by the use of iromunofluorescence
assay using fluorescein-conjugated rabbit anti-bovine IgM
(107).

There was a corresponding decrease

in the absolute number of T lymphocytes using E—rosette
formation for enumeration of these cells.
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A decrease in
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the concentration of IgM in the serum was also observed
using quantitative radial immunodiffusion.

The data

reported suggest that BLV-infection may induce a state of
immunosuppression.
A comparison of the absolute numbers of bovine T
lymphocytes in the peripheral blood of adult asymptomatic or
aleukemic (AL), PL and BLV-negative cattle may indicate that
there is an expansion or depletion of these cells m
AL or PL animals.

either

This alteration in T lymphocyte numbers

may indicate that the T lymphocyte population is affected by
BLV infection.
Identification of peripheral blood lymphocytes of
cattle has been performed mainly on animals which exhibit PL
or LS <110*72,51,156*46).

Very few studies have been

reported on the AL animal (72).

Techniques which have been

used to identify bovine B lymphocytes in BLV-infected cattle
include the EAC resetting technique (142) and Fc receptor
(85) and surface immunoglobulin (slg) immunofluoresence
assays (110,B5,).

Techniques which have been used for

bovine T lymphocyte enumeration include E-rc-sette formation,
(142) an assay for terminal deoxynucleotidy1 transferase
activity (71), anti— thymocyte serum (ATS) and peanut
agglutinin (PNA) cell surface fluorescence assays <B4,147>.
The

use of the above techniques for T lymphocyte

enumeration has led to conflicting reports as to the numbers
of these cells in normal and BLV-infected cattle.
Recently, specific monoclonal antibodies (MAbs) that
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distinguish bovine T and B lymphocytes have been developed
and characterized (90).

An anti-pan T cell antibody (B26a)

that reacts with the sheep red cell receptor on the surface
of T lymphocytes and an anti— IgM antibody'(PIgASA) that
reacts with cell surface IgM (slgM) have been characterized
as markers for bovine T and B lymphocytes) respectively
(90).

The specificities of these two MAbs mere determined

using microcytotoxicity)

dual fluorescence microscopy) and

flow microfluorimetry (FMF).
The present investigation was undertaken to determine the
frequencies and absolute number of bovine T and B
lymphocytes in the peripheral blood of AL and PL animals by
FliF using MAbs that distinguish these cells.

MAbs and

fluorescein labelled PNA (PNA—FITC) were used for T
lymphocyte enumeration anti— IgM and fluorescein labelled
rabbit anti-bovine immunoglobulin (Rblg—FITC) for B
lymphocyte enumeration.

XII. B. MATERIALS AND METHODS

III. B. 1. Animals
A total of 12 cows at least 3 years of age were used in
this study.

Animals were acquired from sale barns in

Southern Louisiana and were maintained at the Veterinary
Medical Farm of the Louisisana State University Agricultural
Center) Louisiana State University School of Veterinary
Medicine) Baton Rouge) Louisiana.

The BLV infection status

was monitored by detection of serum antibodies to BLV
structural antigens using the agar gel immunodiffusion assay
<49).

Of the 12 cattle tested* 4 were negative for BLV

antibodies* 4 were clinically normal but had BLV antibodies
<AL), and 4 were diagnosed as having PL using the criteria
of the International Conference on Bovine Leukosis (> 7.? x
ID3* lymphocytes/mm3 of whole blood for over a period of 3
months)

<2).

Animals were also vaccinated for various

bovine viral diseases and screened for infection by other
lymphotrophic retroviruses*

bovine syncytial virus (BSV) and

bovine visna-like virus <EVV).
VIZI and Table VIII.

(For details* see Chapter

1.)

III. B. 2. Isolation of Peripheral Blood Mononuclear
Cells
Peripheral blood was collected by Jugular venipuncture
into 20 ml vacutainer tubes containing 10 units/ml of
Pan he pr in’* (Abbott Laboratories).

The heparinized blood was

then diluted in an equal volume of phosphate buffered saline
(PBS)* pH 7.4.

Twenty ml aliquots were layered onto 20 ml

of sodium diatrizoate/ficoll (Histopaque” 1077* Sigma
Chemical Co.USA) in 50 cc conical centrifuge tubes (Costar*
Cambridge MA).

The gradients were centrifuged for 30 min at

1DO0 x g at room temperature* and the bands at the interface
between the plasma layer and HistopaqueR were collected and
uashed twice in PBS at 500 x g for 10 min at room
temperature.

Viability counts were performed using the

trypan blue exclusion method.

The cell concentration was
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adjusted to 10 x 10^ cells/ml with PBS.

The peripheral

blood mononuclear cell (PBMC) preparation usually contained
greater than 95X viable cells and less than 2X contamination
with granulocytes.

(Refer to Figure 111. 1. for flow

diagram.)
III. B. 3. Complete Blood Counts
Animals were bled by venipuncture every 2-3 weeks for a
period of 3 months to give a total of A counts per animal.
Blood was collected in tubes containing
ethylenediaminetetraacetic acid as an anticoagulant.

Total

leukocyte counts were made on an automatic cell counter.
Blood smears were prepared and stained by the Wright method*
and differential counts were made.
III. B. 4. Staining CelIs for B and T Lymphocyte
Enumeration
PBMC were isolated from each animal twice at 30 day
intervals.

To identify B lymphocytes*

3 x 10* PBMC were

incubated with either 100 ul (0.74 mg/ml) fluoresceinconjugated F(ab')=. fragments of rabbit anti— bovine IgG* H &
L chains specific (Rblg—FITC)

(Cappel Labs* Cochranvi1le*

PA> or 10 ul (1 mg/ml) of hab PIg45a (14. Davis* Washington
State University*

Pullman* U A . ).

To identify T lymphocytes*

3 x lO* PBMC were incubated with either 100 ul (1 mg/ml)
PNA-FITC (E.Y. Laboratories, U.S.A.) or 10 ul (1 mg/ml) pan
T cell Mab

B26a (W. Davis* Washington State University,

Pullman* W A . ).

Cells were incubated for 3D min at 4 C in

the dark* then washed twice in 1 ml aliquots of PBS with
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0.02% Nahl3 to prevent antibody‘capping.

The washed

preparations of antibody coated cells (PIg45a and E26a) were
then reacted with 100 ul cf fluorescein-conjugated goat
anti-murine IgGf Igrt, IgG mix (GaM-FITC)
Cochranville, PA>,
described above.

(Cappel Labs.,

incubated for 30 min at 4 C and washed as
All cells were fixed with 1 ml 0.5%

formalin in PBS NaN3 .

An aliquot of cells were reacted with

GaM-FITC as a control for nonspecific binding.
III. B. 5. Detection of F 1uorescence—positive CelIs
Fluorochrome labelled cells were enumerated by FMF
(90).

The instrument used for screening and analysis was

the mercury arc lamp based flow cytometer (Becton Dickinson
Hg— arc F A C S ™ Research Analyzer, Becton Dickinson
Immunocytometry Systems Inc.* Mountain View, CA).

The

instrument measures individual cells simultaneously for
fluorescence (autofluorescence and fluorescence imparted by
fluorochrome— coupled antibodies or other specific
fluorochrome reagents bound to a cell membrane), size
(measured by electronic volume) and granularity (measured by
wide angle light scatter).
Data on 5000 cells were collected in list mode on each
sample for analysis.

Two parameter data, scatter versus

fluorescence were recorded in dot plot, contour plot (with
concentric lines outlining areas of highest cell density)
and isometric display using the data analysis programs
provided for the Beckton Dickinson Consort 30.

The percent

of labelled cells was determined with the computer program
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by setting a marker at the appropriate channel on a contour
profile of control cells (exposed to GaM-FITC alone) such
that 95% of the signal imparted by cells fell between
channels 10 and 80.

Erythrocytes and platelets were

excluded from analysis by setting the trigger threshold and
gates to exclude low scatter and low volume signal* thereby
excluding cells smaller than lymphocytes.
III. B. 6.

Statisiteal Analysis

The statistical significance of the total UBC*
lymphocyte* and absolute B and T lymphocyte counts was
assessed with an unpaired Student's t test (136).

III. C.

RESULTS

III. C. 1.Hemogram
The total UBC and lymphocyte counts used for
statistical evaluation were obtained from 4 individual
bleeding times (2-3 weeks apart) for each animal.

Four

animals were evaluated from each group of AL* PL and BLV—
negative control animals.

The mean UBC from BLV—negative

cattle was 6.7 x 103/mm3 of whole blood* from AL animals*
9.7 x 103/mm3 * and from PL animals* 26.5 x lCP/mnr* (Fig.
III.2).

The mean lymphocyte counts from BLV—negative cattle

was 3.3 x lCP/mm3 * from AL animals* 5.0 xlO^/mm3 * and from
PL animals was 23.5 x lO^/mwr* (Fig. III. 2).

These data

show that there was a significant increase (p < 0.005) in
the both the UBC and lymphocyte populations in the
peripheral blood of AL and PL cattle tested (Table III. 1).
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III. C. 2. Frequencies of T and B Lymphocytes
A FMF analysis of one representative animal from each
BLV group (BLV-negative* AL and PL animals) was selected to
demonstrate the staining characteristics of that group.
Animal R 56 represents the BLV—negative group of animals
(Fig.

III.3).

Animal Y 75 represents the AL group (Fig.

III.4) and animal B 10 represents the PL group (Fig. III.5).
When PNA was reacted with PBMC from BLV-negative, AL and
animals,

three patterns of labelling were observed.

PL

In

uninfected animals* T lymphocytes invariably exhibited high
expressions of the PNA receptors (Fig.

III. 3a).

B

lymphocytes and null cells exhibited low expression or
inapparent expression (i.e.*
detected by FMF).

levels of expression not

Cells from animals in the AL phase

contained a high percentage of brightly stained PNA positive
cells and a small population of the dimly stained PNA
positive cells (Fig. III. 4a).

In contrast*

in cell

preparations from PL animals* a large population of dimly
stained PNA positive cells were present and there was only a
small population of brightly stained cells (Fig. III. 5a>.
When PBMC from normal* AL and PL cattle were reacted
with B26A (pan T cell antibody)* the positive cells
corresponded to the brightly staining PNA cells (Figs.
3b*4b*5b).

III.

The percentage of B26a positive cells ranged

from 10—20% fewer than PNA positive cells (Table III. 2).
There was a decrease in the percentage of labelled cells (
PNA or B26a) in the PBMC of PL animals.

Cells which reacted with Rablg—FITC (sly*) and PIg45A
(slgM-*") corresponded with the percent of dimly staining PNA
positive cells in all animals tested (Figs.
III.3c,d,4c,d,5c,d).

The percentage of slgM* cells

corresponded with the slg"~ cell population (Table III.2).
In the PL animals,

the staining intensity was much greater

for the slgli* bearing cells than for the slg* cells (Fig.
III. 4c,d>.

This indicated that the majority of B

lymphocytes in the PBMC of these animals were IgM— bearing
cells and that these cells contain large quantities of IgM
on their surfaces.

The percentage of slgM* cells equaled

the percentage of slg* cells in most cases (Table III. 2).
These results indicated that even though the anti— IgM
antibody was an intact Ig molecule,

it was not binding to

cells other than B lymphocytes via the receptor for the Fc
portion of the Ig molecule.

There was an increase in the

percentage of both slg“" and slgM* cells in the PBMC of PL
animals when compared to either AL or BLV—negative control
animals.
The pattern of labelling differed only in one animal,
632 (Fig.

III. 6).

This was a PL animal with a high level

of lymphocytes (72 x 103 /mm3 of whole blood) of which B75i
were positive for the PIg45A marker (Table III.2). A number
of slg~ cells appeared to react with both B26A and PIg45A
suggesting the cells may co-express slg and the B26A
antigen. The staining characteristics of this animal's PBMC
showed that the majority of its cells stained very intensely
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with the PIg45a marker,

indicating that these cells had

large quantities of IgM on their surfaces (Fig. Ill, 6d)
III. C. 3.

Absolute Numbers of T and B Lymphocytes

The absolute numbers of T and B lymphocytes (B26a"‘ and
slgM*) in the PBMC of animals tested were determined by
multiplying the percentage of these cells by the total
lymphocyte counts.

Four animals in each group of AL and

BLV-negative control animals and 3 PL animals were used.
Lymphocytes harvested from 2 bleedings (30 days apart) were
used in this study.

Data on 500P cells were collected for

each sample tested.

The statistical information was

obtained by using raw data for each group (Table III. 3).
The absolute numbers of B and T lymphocytes in the
peripheral blood of the BLV-negative* AL and PL animals
tested are summarized in Figure III. 7.

The number of T

lymphocytes in the PBMC of AL and PL animals was
significantly higher (significance at the level of (p <
0.DOS) than those of BLV— negative animals (Table III. 3).
The number of B lymphocytes in the FBMC of PL animals was
significantly higher than that of BLV—negative control
animals (p < 0.005).

There was no significant difference in

the number of B lymphocytes in the PBMC of AL animals when
compared to BLV—negative control animals.
Absolute numbers of B and T lymphocytes from the PBMC
of animal 632 were not averaged into the counts for PL
animals because under the labelling conditions used in this
study we were unable to distinguish B from T lymphocytes
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because a cell population appeared to stain with both T and
B lymphocyte markers.

III. D. DISCUSSION
Monoclonal antibodies were used to determine the
frequencies of T and B lymphocytes in the peripheral blood
of AL and PL cattle using monoclonal antibodies that
distinguish these cells.

An overall increase in the

lymphocyte population in AL and PL animals tested when
compared to BLV—negative control animals.

The increase in

the lymphocyte numbers of AL animals was attributed to an
increase in the T but not the B lymphocyte population.

In

the PL animals* an increase in both the T and B lymphocyte
populations was observed.

These experiments indicate that

not only the B lymphocyte population but also the T
lymphocyte population may be affected by BLV infection.
In order to assess the increase of B and T lymphocytes
in the peripheral blood of AL and PL cattle*

it was

important to look at absolute numbers of these cells based
on their frequencies in the PBMC and relative to the total
lymphocyte counts.

Relying on the percentage of cells alone

leads to an inaccurate assessment of the number of cells
present in the circulation of individual animals because of
the increase in the total lymphocyte numbers in AL and PL
animals.

Most of the information reported on T and B

lymphocytes in BLV-infected animals is reported as
percentages not as absolute numbers (72*B5*142).

This is

45

probably the main reason that the increase of T lymphocytes
in these animals has gone unnoticed.
The use of MAbs to assay bovine T and B lymphocytes has
many advantages over other methods of evaluation (i.e. SRBC
rosetting, enumeration of the Fc receptor positive cells*
ANAE staining).

These methods are tedious* and the results

have been difficult to reproduce in different laboratories.
In cattle* these techniques have yielded wide ranges of
values for peripheral B and T lymphocytes (72*142*84).
Moreover*

it has been demonstrated that up to 10% of E—

rosetting bovine PBMC may be slg~ (147).

The existence of a

population of T lymphocytes having receptors for the Fc
fragment of IgG has also been demonstrated (147).

These

findings could account for some for the variability
previously observed in the characterization of the
frequencies of T and B lymphocytes in BLV-infected animals.
In the experiments reported here* an anti— IgM antibody of
the IgM subclass and F(ab')2 fragments of IgG mere used to
enumerate bovine B lymphocytes and to avoid possible
nonspecific staining of other PBMC.
PNA-FITC mas found to stain T lymphocytes brightly and
B lymphocytes and null cells dimly* forming two distinct
populations with cells from most animals tested.

Cells

labelled with B26A and Rablg and Pig45A corresponded with
the brightly and dimly PNA-FITC labelled cells respectively.
Preliminary studies using dual fluorescence analysis with
granulocyte free HistopaqueR purified PBMC* fluorescein

labelled PNA versus phycoerythrin—avidin biotinated GaMIg
revealed B26A reacts with cells expressing a high
concentration of the PNA receptor and that RbXg—FITC and
PIg45A react with cells expressing a low concentration of
PNA (90).

Therefore* the data presented in this report is

in agreement with these findings.

The staining

characteristics of PIg45a closely parallel those of Rablg
indicating that this marker is highly specific for bovine B
lymphocytes. These results give further evidence that the
MAb markers are specific for the lymphocyte subsets.
The staining characteristics of lymphocytes from animal
632 seem to indicate that there is a subpopulation of
lymphocytes in some BLV-positive cattle with very high
lymphocyte, counts that carries both B and T lymphocyte
markers on their cell surfaces.

This is an observation

consistent with SRBC resetting studies reported previously
(147).

Additional studies by dual fluorescence analysis are

needed to analyse carefully the antigen expression on the
cells in this animal.

There is also an increase in the

number of cells that bind the PIg45A MAbs alone.
antibody is an anti-bovine IgM antibody*

Since this

it suggests that PL

is attributable* at least in part* to an ‘increase in the
number of slgM-bearing lymphocytes. These cells are most
likely immature (virgin) or memory B lymphocytes (142).
Perhaps this is the BLV-infected population.

This

hypothesis may be proven by isolating this population of
cells and performing DNA hybridization on its purified DNA

47

with a specific BLV-DNA probe.
Some of the BLV—negative and BLV-infected animals used
in this study

had concurrent infections with other bovine

lymphotrophic viruses (Table VIII.

1).

There did not appear

to be any correlation between the infection with other
retroviruses* BSV and B W

and the BLV status (AL or PL) of

the animals used in the above study.
that both BSV and BVV
(148* 149*11*96).

Ithas been reported

have been found in

PL and LS animals

It was once considered that these viruses

were responsible for EBL (148*149*11).

However*

it was

found that the incidence of infection by these viral agents
in PL or LS animals was low (<2570* whereas* greater than
9DTi of animals with EBL have antibodies to BLV antigens.

No

direct connection between either of these virus infections
and the AL or PL state has ever been established (96).
All AL and PL animals were positive for BLV antibodies
throughout the course

of this study. In

increase in the total

WBC* lymphocyte

cattle with PL* an
count and B lymphocyte

population in the peripheral blood has been documented
<110*85*72).

An elevation in the T lymphocyte population in

PL animals has not been previously reported.

This study is

also the first documentation of an elevation of the T
lymphocyte population of AL cattle.

Therefore* the data

obtained from the experiments reported herein suggest that
there is an alteration in the T lymphocyte numbers of BLVinfected animals.

Identification of the particular T

lymphocyte subset that is affected by BLV-infection must
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wait for the development of additional monoclonal antibodies
to bovine T lymphocyte markers.
The reason for increase in the numbers of T lymphocytes
in the peripheral blood of AL and PL animals is unclear.
The T lymphocyte may be a target cell for BLV infection and
as a result of infection there could be a T-cell
lymphocytosis.

To address this hypothesis* DNA from

purified T lymphocytes of BLV-infected animals must be
acquired and DNA hybridization analysis must be performed
using a highly specific BLV—DNA probe.

The T lymphocyte

population may be responding to the presence of a serum
protein(s) which may augment the mitogenesis of these or a
subpopulation of T lymphocytes.

It has been shown that the

BLV proviral genome codes for a trans activational
transcriptional protein (tat? which mediates transcriptional
activation of BLV proviral gene sequences and perhaps host
cellular genes (131).

Perhaps* this gene product is

responsible for augmenting the T and B lymphocytosis
observed in BLV-infected animals.
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Table III. 1. Statisical Analysis of VJBC and
Lymphocyte Counts from Bovine Leukemia
Virus Infected Cattle

BLV* Status

T Value

Degrees of
Freedom

P Value

WBC
BLV (-) Vs BLV (AL)

4.942

29

'0.005

BLV (-) VS BLV (PL)

3.322

30

0.005

BLV (-) Vs BLV (AL)

5.439

28

0.005

BLV (-) VS BLV (PL)

3.268

29

0.005

Lymphoc\rtes

BLV (-) = Cattle with no detectable serum antibodies
to BLV antigens using- iitmunodiffusion test.
BLV (AL) - Cattle with detectable serum antibodies to
to BLV antigens but have no clinical signs of disease.
BLV (PL) = Cattle with detectable serum antibodies to
BLV antigens and have persistent lymphocytosis.

Table III. 2. Frequencies of T and B Lymphocytes from
the Peripheral Blood of Bovine Leukemia
Virus Infected Cattle

*
BLV
Status

No. of
Animals

Percent o£^Positive Lymphocytes
% T
% B **
PNA

B26a

SIg

SIgM

BLV (AL)

4

82 + 6+ 66 ± 9

16 + 11 21 + 13

BLV (PL)

3

45+3

53 + 16 58 + 11

BLV (-)

4

79 + 11 56 + 12 26 +, 6

26 + 7

1

44 + 11 57 + 6

77 ± 11

632++

34+6

87 + 7

*

BLV Status indicates: BLV (-) = Cattle negative for BLV
antibodies. BLV (AL) = Cattle positive for BLV antibodies
but no clinical signs. BLV (PL) - Cattle positive for
BLV antibodies and have persistent lymphocytosis.
**

Frequency of T lymphocytes detected by peanut agglutinin
(PNA) and monoclonal antibodies to pan T cells using
microfluorimetry. Frequency of Blymphocytes detected by rabbit anti-bovine
IgG (h & L chains specific) (F(ab’)2 fragments and
monoclonal antibodies to surface bound IgM using
microfluorimetry.
+
Mean ar standard deviation
++
PL animal with high lymphocyte count.
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Table III. 3. Statistical Analysis of T and B Lymphocytes
frctn Bovine Leukemia Virus Infected Cattle

BLV*
Status

T Value

Degrees of
Freedom

P Value

T Lymphocytes
BLV (-) vs BLV (AL)

5.599

12

0.005

BLV (-) vs BLV (PL)

5.382

14

0.005

BLV (-) vs BLV (AL)

0.132

14

BLV (-) vs BLV (PL)

6.250

12

B Lymphocytes
**
N.S.
0.005

*

BLV (-) = Cattle with no detectable serum antibodies
• to BLV antigens using immunodiffusion test.
BLV (AL) = Cattle with detectable serum antibodies to
BLV antigens but have no clinical signs of disease.
BLV (PL) = Cattle with detectable serum antibodies to
BLV antigens and have persistent lymphocytosis.
**

Not significant at the level P = 0.1.

CHAPTER

IV:

PURIFICATION OF T LYMPHOCYTES FROM BOVINE

PERIPHERAL BLOOD MONONUCLEAR CELLS USING IMHUNO
AFFINITY DEPLETION (“PANNING")

IV. A.

INTRODUCTION

It has been documented that B lymphocytes are target
cells for bovine leukemia virus (BLV), the etiologic agent
of enzootic bovine leukosis (EBL> (8,108,75).

The role that

T lymphocytes play in the disease process is unknown.

It

was demonstrated that there is an increase in the number of
circulating T lymphocytes in BLV-infected aleukemic (AL> and
"s.

persistent'lymphocytotic (PL) animals (Chapter III).
Purified T lymphocyte populations are necessary to determine
the significance of this increase in the progression of EBL.
There are numerous techniques for purification of T
lymphocytes from human and mouse peripheral blood
(£4,86,134).

However, no techniques are currently available

for the efficient separation of large quantities of bovine
lymphocyte subsets.

Purification of peripheral blood

mononuclear cells (PBMC) is done routinely by centrifugation
on ficoll of density 1‘.077 g/ml

(146).

Attempts to

accomplish further separation of bovine T lymphocyte subsets
using various techniques have failed to give reproducible
separation results.

Purification of bovine T lymphocytes by

nylon wool adherence has given high purity of these cells,
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however the yield of purified cells uias less than 37. of the
original cells applied (121).

Antibody-complement

immunolysis has been used to selectively deplete B
lymphocytes from PBMC of cattle and enrich the T lymphocyte
population but recoveries are also law (146).
The efficient separation of murine T lymphocytes has
been reported using plastic surfaces coated with anti-murine
immunoglobulin antibodies.

This technique is referred to as

immuno-affinity depletion ('panning")

(92).

This technique

has' £-iven good yields of highly purified murine T
lymphocytes.

Polystyrene surfaces have also been employed

as an insoluble matrix for the affinity reagents used to
separate lymphocyte subpopulations from other species
(95jl63).

A procedure using “panning" has not been reported

for the efficient separation of bovine T lymphocytes.
Surface markers have been used to identify bovine
lymphocytes (Refer to Chapter III).

Those cells staining

with anti-bovine immunoglobulin conjugated with fluorescein
isothiocyanate (slg-bearing cells) are suggested to be B
lymphocytes (B5*55)» and those staining with peanut
agglutinin conjugated with fluorescein isothiocyanate (PNAFITC), T lymphocytes (124*55).
The purpose of the present investigation was to explore
the application of "panning" to enrich T lymphocytes from
the PBMC of BLV— infected cattle so that large numbers of
these cells could be obtained for further testing.

The

"panning" technique is based on the fact that bovine B
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lymphocytes have immunogiobulin

<Ig> on their cell surfaces

and that bovine T lymphocytes do not.

Therefore*

plastic

surfaces coated uiith anti-bovine Ig will specifically bind
and therefore deplete B lymphocytes from PBMC.

The T

lymphocytes can then be recovered from the nonadherent cell
fraction.

IV. 3.

MATERIALS AND METHODS

IV. B. 1.

Isolation of Peripheral Blood Mononuclear
Cells

Forty ml of peripheral blood were obtained by
venipuncture of the Jugular vein from adult AL cows (Y 12* Y
32, Y 74) and BLV-negative cows (R 52, R 56)
Chapter VIII).

(Refer to

The blood was diluted in an equal volume of

phosphate buffered saline (FBS), pH 7.4.

Twenty ml of

diluted blood were layered on 20 ml of Histopaque" (density
1.077 g/ml)

(Sigma* U.S.A.),

in 50 ml polypropylene*

conical

centrifuge tubes (Costar* U.S.A.) and centrifuged at 1000 x
g for 30 min at 25 C.

Cells at the interface between the

plasma and Histopaque" phases were removed with sterile
Pasteur pipettes* washed twice with PBS <500 x g for 10 min
at 25 C), pooled and resuspended in 2 ml PBS.

Cell

viability was determined by the trypan blue exclusion test*
and the cell suspension was diluted to a concentration of
2.0 x IQ7 cells in PBS.
diagram.)

(Refer to Figure III.l. for a flow
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IV.

B. 2. Coating Plastic Flasks with Immunogiobulin

To coat polystyrene tissue culture flasks with antibovine Ig a previously described procedure (92) was used
with the following modifications.

Two ml (2.5 mg/ml) of

F ( a b ')s fragments of rabbit anti— bovine IgG, heavy and light
chains specific (anti— bovine Ig) (Cappeli U.S.A.) were added
to each 25 cm2 polystyrene tissue culture flask (Costar,
U.S.A.).

The concentration of anti-bovine Ig was critical?

if less than 5 mg per flask were used* the yield and purity
of the T lymphocyte preparation were low.

The flasks were

incubated on a level table for 19-24 hours at 4 C to
optimize Ig binding.

Immediately before use* the unbound

anti-bQvine Ig was transferred to a new, sterile flask which
was then stored at 4 C for future use.

The Ig-coated flask

was then washed four times, each time with 5 ml PB5.
IV. B. 3.

Affinity **Panning" Procedure

The PBMC were gently agitated to assure a single cell
suspension.
coated flask.

Two ml (4.0 x 107 cells) were added to an IgThe flask was placed on a level table and

gently swirled to assure even distribution of the cells over
the entire dish.

After incubation for 15 min at 25 C, the

nonadherent cells were carefully resuspended by rocking the
flask, then removed with a pipette and washed twice with PBS
(500 x g for 10 min at 25 C).

Maximum binding of cells to

precoated surfaces was determined to occur within fifteen
minutes of incubation at 25 C.

Longer incubation times did

not increase the cell binding capacity.

Shorter incubation
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periods resulted in lower T lymphocyte yield and higher slg—
bearing cell contamination.

Cell viability was determined

by trypan blue exclusion test, and the cells were
resuspended to a concentration of 10 x ID*" viable cells/ml
in PBS to prepare for quantitation of lymphocyte subsets and
monocytes.

(Refer to Figure IV. 1. for a flow diagram.)

IV. B. 4. Determination of Lymphocyte Subsets and
Monocytes
For detection of contamination with slg bearing cells,
nonadherent cells were incubated with fluorescein-conjugated
F(ad')a

fragments of rabbit anti-bovine IgG, heavy and

light chains specific <Rablg-FITC>, (Cappel, U.S.A).

To

detect T lymphocytes, nonadherent cells were incubated with
PNA-FITC (E.Y. Laboratories,

U.S.A.).

Approximately, 0.3 ml

(3.0 x 10^ ) cells were mixed with either 0.1 ml <0.74
mg/ml) of Rablg-FITC or 0.1 ml

(2.5 mg/ml) PNA-FITC.

The

cells were incubated for 30 minutes at 4 C then washed twice
(500 x g for 10 min at 25 C) with 1 ml of PBS containing
0.02% NaN3 . This concentration of NaN? was used to insure
that capping and shedding of Igs did not occur on the slgbearing cells.
Rablg-FITC and PNA-FITC positive cells were enumerated
by counting 200 cells at 1000 x magnification with the aid
of a fluorescent microscope equipped for phase contrast and
incident UV light i 11 uniin at ion (Leitz, Germany).

The

detection of monocytes in the nonadherent cell population
was accomplished by using a nonspecific esterase staining
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procedure (83).

IV. C.

RESULTS

IV. C. 1.

T Lymphocyte Vield after "Panning*

The results Df T lymphocyte recovery or yield after
■panning* using the PBMC of coins are summarized in Figure
IV. 2.

An average of 31 x 10** PNA-positive (T lymphocytes)

were added to an anti— Ig coated flask.
15 minutes,

After incubation for

the T lymphocyte recovery in the nonadherent

fraction averaged 15 x 10** cells.

This was an average yield

of 48%.
IV.

C. 2.

T Lymphocyte Enrichment and B Lymphocyte

Depletion
The results of T lymphocyte enrichment from PBMC using
■panning* are summarized in Figure IV. 3.

After separation

on a density gradient of HistopaqueR , the PBMC fraction
consisted of an average of 77% T lymphocytes.

After

“panning", the nonadherent cell fraction was composed of an
average of 95% T lymphccyte population.
An average of 85% of the slg-bearing cells were
depleted from the PBMC using "panning"

(Fig.

IV. 4).

B

lymphocytes accounted for an average 3% of the contaminating
cells in the nonadherent fractions.

The rest of the cells

were not identified by the methods used and were assumed to
be null cells.

Non—specific esterase— positive cells

(monocytes) were not detected in the nonadherent cell
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fractions.

IV. D. DISCUSSION

An affinity depletion technique for the efficient
enrichment of bovine T lymphocytes from peripheral blood has
been described.

Antibodies to bovine Igs attached to

polystyrene tissue culture flasks mere used to separate slgbearing cells from T lymphocytes.

The T lymphocyte yield

and purity using "panning" on the PBMC of cattle is higher
than any method previously reported. For example*

the use of

nylon wool adherence to deplete B lymphocytes from PBMC
resulted in high T lymphocyte purity (96%) but low cell
recovery (2.5%) in the nonadherent fraction (121).

However*

the use of "panning" resulted in a 95% T lymphocyte purity
and 48% recovery.
This technique gave reproducible results with BLVinfected AL animals (Y 12* Y 32 and Y 74) and BLV-negative
control animals (R 52 and R 54) which had normal white cell
counts in the range of 6.8-9.B x lCF/mm3 in whole blood and
52—64% lymphocytes (121).

“Panning" did not give good

yields (< 10%) of purified T lymphocytes from PBMC of BLVinfected cattle which exhibited a persistent B cell
lymphocytosis (PL).

These animals typically had elevated

WBC (> 7.5 x lCP/mm3 in whole blood).

They also had a high

percentage of lymphocytes (> 50%)* of which the majority
60%) were slg-bearing cells.

(>

When PBMC from these animals

were added to an anti-Ig coated flasks, the number of slgbearing cell binding sites on the flask apparently became
saturated* and the nonadherent cell fraction mas highly
contaminated with slg-bearing cells.

Therefore,

in order to

obtain an efficient T lymphocyte recovery with high purity,
modification of the above procedure was attempted.

A second

■panning" step to remove the slg— bearing cells not bound by
the first "panning" was employed.

This technique did not

give good yields of highly purified T lymphocytes.

0 trier

separation techniques such as B lymphocyte depletion by
antibody, complement-mediated cytolysis (14&), and
separation on PercollR density gradients as well as affinity
column chromatography using Affi-Gel anti—FITC columns <
BioRad, U.S.A.) were used to attempt to purify T lymphocytes
from the PBMC of PL cattle.

No procedure gave good yields

of purified T lymphocytes from these animals.
The affinity "panning" for efficient enrichment of
bovine T lymphocytes from PBMC of normal and AL cattle was a
simple, reproducible method that gave a highly purified,
viable T cell population in as little as two hours.

The

procedure used a minimal amount of reagents, and the unbound
anti— Ig could be transferred and used up to three times
without loss of T lymphocyte purity or yield.

The technique

yielded 20-40 >: ID*5* T lymphocytes from 40 ml of whole blood.
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ADD 2 ML (2.5 MG/ML)
F(AB’)2 FRAGMENTS OF
ANTI-BOVINE IgG
H&L CHAINS
SPECIFIC
INCUBATE 18 H AT 4°C
........

s

REMOVE UNBOUND IgG
WASH X 4 - 5 ML PBS
ADD 2 ML
(4 .0 X 107) PBMC

INCUBATE X 15 MIN AT 2 5 °C
TO BIND IgG BEARING CELLS (B CELLS)

NONADHERENT
CELLS
(T CELLS)

GENTLY
AGITATE

WASH X 2 WITH PBS
( 5 0 0 X G FOR 1 0 MIN )

Figure IV . 1. Procedure f o r T Lymphocyte P u r if ic a tio n
using "Panning".
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Figure IV.2. T Lymphocyte Yield after "Panning" of Bovine
Peripheral Blood Honnuclear Cells using AntiBovine Immunoglobulin Coated Flasks
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Figure IV.3. T Lymphocyte Enrichment by "Panning"of Bovine Peripheral
Blood Mononuclear Cells using Anti-Bovine Immunoglobulin
Coated Flasks.
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Figure IV.4. Depletion of B Lymphocytes by "Panning" of Bovine
Peripheral Blood Mononuclear Cells using Anti-Bovine
Immunoglobulin Coated Flasks.

CHAPTER V:

ASSESSMENT OF THE PRESENCE OF BLV PROVIRUS IN

THE T LYMPHOCYTES OF BLV-INFECTED* ALEUKEMIC CATTLE

V. A.

INTRODUCTION

The bovine leukemia virus (BLV)* an exogenous (14)
leukemogenic virus of the family Retroviridae*

has been

implicated as the etiologic agent of enzootic bovine
leukosis (EBL)

(108).

This virus may infect cattle and not

produce any clinical signs of disease.
referred to as aleukemic (AL) cattle.

These animals are
The virus may also

induce two clinical manifestations of diseasepersistent
lymphocytosis (PL) or malignant lymphosarcoma (LS)
Since* EBL is a neoplasm of the lymphoid system*

(46).

cells of

the lymphocyte lineage were the first candidates to be
suspected as preferred BLV targets.

This was shown to be

correct by demonstration of BLV production in vitro from
cultures of peripheral blood mononuclear cells (PBMC) from
BLV-infected cattle (108).

Also* molecular hybridization

analysis using a single-stranded BLV cDNA probe for
detection of BLV proviral sequences in the white blood cells
of PL cattle confirmed the presence of BLV in the
lymphocytes of these animals (76).
By using the nylon wool separation procedure to
fractionate the B and non—B populations of bovine peripheral
blood and subsequent in vitro cultivation of these cells*
was shown that the capacity to produce C-type particles
resided with the B lymphocytes (124).
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It

was also found that the majority

of lymphocytes present

in

the peripheral blood of PL and LS cattle and in

had markers typical of B lymphocytes (110,85,72).

tumors
This

information led to the conclusion that the B lymphocyte is
the target cell of BLV infection.

A recent study indicated

that lymphoblastoid-l ike cells derived from two EBL tumors
had cell surface markers typical of T lymphocytes and that
the cells from these cultures contained BLV provirus (91).
It

has been demonstrated that there

is an increase in the

absolute number of T lymphocytes in
AL and PL animals (Chapter 111).

the peripheral blood of

These studies suggest that

T lymphocytes of BLV-infected animals may either be infected
by BLV or are responding to the presence of the virus or
viral proteins.
Definitive studies on highly purified T lymphocyte
populations from the peripheral blood of animals with AL or
PL have not been conducted.

The main reason that this

research has not been done is that purification techniques
which yield large quantities of highly purified T lymphocyte
preparations have not been available.

A technique using

immuno-affinity depletion "panning* to deplete B lymphocytes
from PBMC of cattle has recently been reported (Chapter IV,
ld»l).

This technique gives good yields of highly purified

bovine T lymphocytes from AL but not PL animals.
The purpose of this investigation was to assess the
presence of the BLV provirus in the DNA of immuno—affinity
purified bovine T lymphocytes from AL cattle using DNA

hybridization with a highly specific* nick-translated 3ap—
BLV-DNA cloned probe.

V- B.

MATERIALS AND METHODS

V. B. 1. Animals
A total of 7 animals were used in this study (R 52*
73* Y 12* Y 32* Y 74, Y 75 and B 10).

(For more details

refer to Chapter VIII and Table VIII.

1.)

Y

The cattle were

examined clinically and hematologically for signs of bovine
leukosis using the guidelines of the International
Conference of Bovine Leukosis (2).

BLV infection was

monitored by detection of serum antibodies to Bi_V structural
antigens using the agar gel immunodiffusion assay (33).

Of

the 7 animals* 2 were BLV-negative* 4 were AL and 1 one was
a PL animal.
V. B. 2. Isolation of PBMC
Large quantities of cells were required <1 x 10B
cells) for DNA purification.

Therefore* 5DD ml of

peripheral blood were collected by venipuncture into vacuum
bottles containing Panheparinw * 10 units/ml whole blood
(Abbott Laboratories, U.S.A.).

The heparinized blood was

then diluted in an equal volume of phosphate buffered saline
(PBS)* p H 7.4.

Twenty ml aliquots were layered onto equal

volumes of sodium diatrizoate/ficol1 * 1.077 g/ml
(Histopaque** 1077* Sigma Chemical Co. * U.S.A. ) in 50 cc
conical centrifuge tubes (Costar* U.S.A.).

The gradients
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uere centrifuged for 30 min at 1000 x g at room temperature.
The bands at the interface between the plasma layer and
HistopaqueR were collected and washed twice in PBS at 500 x
g for 10 min at room temperature.

Viability counts were

performed using the trypan blue exclusion method.

The

lymphocyte preparation usually contained greater than 7b5i
viable cells.
V. B. 3.

(Refer to Figure III.

1 for flow diagram).

Purification of T Lymphocytes

The T lymphocytes were purified from PBMC of BLV—
negative and AL cattle by immuno—affinity depletion
("panning*)i a method previously described (Refer to Chapter
IV.).

Briefly* 4 x IG'7’ PBMC were added to each of six 25

cm2 * polystyrene tissue culture flasks (Costar* U.S.A.).
These flasks had been previously coated with 5 mg of F(ab')2
fragments of rabbit anti— bovine IgG* H and L chains specific
(anti—bov IgG)

(Cappel* U.S.A.)* and incubated for at least

IB hours at 4 C.

The unbound anti-bov IgG was then removed*

and the coated flasks were washed x 4 with 5 ml of PBS.

The

cells were incubated in the immunoglobulin-coated flasks at
25 C for 15 min.

After incubation* the nonadherent cells

were carefully resuspended by rocking the flask* then
removed with a pipette and washed twice with PBS.
Figure IV. 2. for flow diagram).

(Refer to

The nonadherent cell

preparation usually contained 40-502 of the original number
of cells applied.
V. B. 4. Determination of Lymphocyte Subsets and
Monocytes

For detection of B lymphocytes in PBMC and purified T
lymphocyte preparations, 3 x 10** cells were mixed with 100
ul CO.74 mg/ml) of fluorescein— conjugated F(ab')2 fragments
of rabbit anti— bovine IgG* H and L chains specific (RablgFITC) (Cappel* U.S.A.).

This marker has been shown to be

highly specific for bovine B lymphocytes (refer to Chapter
III).

For detection of T lymphocytes!

nonadherent cells

were mixed with 100 ul (2.5 mg/ml) of fluorescein-conjugated
peanut agglutinin—FITC (PNA-FITC)

(Cappelf U.S.A.).

This

marker has been shown to label bovine T lymphocytes (Refer
to Chapter III).

All cell preparations were incubated for

30 minutes at 4 C* then washed twice with 1 ml of PBS
containing 0.02% NaN3 to prevent antibody capping.
Fluorescence-positive cells were enumerated by counting
200 cells at 1000 x magnification with the aid of a
fluorescent microscope equipped for phase contrast and
incident UV light illumination (Leitz* Germany).

The

detection of monocytes in the T lymphocyte preparations was
accomplished by using the nonspecific esterase staining
procedure <63).
V. B. 5. DNA Purification
DNA purification of PBMC and T lymphocyte preparations
was performed as previously described with the following
modifications (101).

Briefly*

1 x 10s cells were lysed in

DNA lysing medium (10 mM Tris buffer pH 7.4*

lOmM

ethylenediaminetetraacetic acid (EDTAf 0.1 M NaCl*

1.0%

Sarcosyl and 10D ug/ml Protease K* Sigma Chemical Co

U.S.A.).

The lysate was digested for 45 min. at 37 C then

either promptly extracted or frozen at —70 C.

The lysates

were extracted 2 x with equal volumes of chloroform:isoamyl
alcohol mixture (24:1) (centrifuged 2*500 x g for 20 min at
25 C).

The chloroform was removed by two cycles of ether

extraction using an equal volume of H20 saturated ether.
Residual chloroform and ether was removed by heating the
preparation to 6B C for 10 min. The salt concentration of
the DNA preparation was adjusted to 0.5 M NaCl.

The DNA was

ethanol precipitated with two volumes of ethanol for at
least 2 hrs at -20 C.

The precipitate was pelleted at

15*000 x g for 15 min at 4 C and resuspended in 1-2, ml Tris
EDTA (TLE) buffer (lOmM Tris, pH 7.4 and 0.1 M EDTA).

The

concentration of DNA was assessed by spectrophotometric
means using 0D2M3 for DNA concentration quantitation and
0D2 M ,/0D2OO ratio as an estimate of purity (135).

One

optical density at 260nm was equal to 50ug of DNA.

A ratio

of from 1.8 to 2.0 (0D2<>o/0D2tsc,) was considered of good
purity.

The DNA was stored at —20 C until used.

(Refer to

Figure V. 1. for flow diagram.)
V.

B. 6. Restriction Endonuclease Digestion and Gel
Electrophoresis
Sac 1 restriction endonuclease (R.E.) (Cooper

Biomedical* U.S.A.) digestions were carried out on the
bovine PBMC and T lymphocyte DNA's using the following
method.

Approximately 5 ug of DNA was mixed with 5 ul of

ID X Sac 1 buffer <60 mM NaCl, 6D mM Tris, pH 7.4, 60 mM
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MgCl, 60 mM 2-mercaptoethanol, and 100 ug/rol bovine serum
albumin), 5 ul of Sac 1 R.E.
a 50 ul reaction mixture.
hr at 37 C.

(10

units/ul), and H^O to make

This mixture was incubated for 2

After digestion was complete, 5 ul of DNA

loading dye (0.25% bromophenol blue, 0.25% xylene cyanol,
and 15% ficoll type 400) was added tD the digests.

The

reaction mixtures were loaded into individual wells of
horizontal, 0.7% agarose (SeaChem agarose FMC U.S.A.) slab
gels.

The Hind III digest of lambda DNA and the Haelll

fragments of 0X174 RF DNA (New England BioLabs, MA) were
used as molecular-weight markers.

Sac 1 digest of DNA from

the fetal lamb kidney cell line which is persistently
infected with BLV (FL.K—BLV)

(153) as well as DNA from PBMC

of PL animal B ID were used as BLV-DNA positive controls.
Sac 1 digests from PBMC and purified T lymphocyte
preparations from BLV-negatiive cows were used as negative
controls.

The DNA was electrophoresed in Tris acetate

buffer (TAE) (0.04 M Tris acetate and 0.002 M EDTA). at 30 V
for 16 hr at 25 C. The gel was then stained for 30 min using
ethidium bromide (EtBr)

(5 ug/ml) and photographed using

long wave UV light illumination and Polaroid Type 57 film.
V. B. 7. Gel Transfer
DNA fragments were transferred from agarose gels to
nitrocellulose filters using the Southern transfer technique
(137).

Nitrocellulose filters were then dried for 2 hr at

60 C in a vacuum oven.
V. B. 8. BLV-DNA Probe

The BLV DNA probe was provided by Dr. James Casey
(Frederick Cancer Res. Inst. Fredrick* MD . ) as a cloned
provirus probe consisting of an EcoRl fragment of FLK-BLV
DNA which contained almost the entire BLV provirus excluding
the 3' long terminal repeat and included 20D base pairs of
cellular flanking sequence DNA (Fig. V. 2).

This fragment

was ligated into a PUC-S vector plasmid and cloned in E.
coli HB101.

This probe hybridized to the 7.5 kilobase (Kb)

fragment of the BLV-provirus DNA in BLV-infected lymphocytes
but hybridization also occurred with a variety of other
fragments in these DNAs and in BLV—negative control animals.
Therefore* the cloned probe was further purified as
described below.
The BLV-DNA probe (ID ug) was digested with Sac 1 to
purify almost the entire BLV proviral genome as a 7.5 Kb
fragment ( Fig. V. 2).

'

The R.E. fragments were then

separated by agarose gel electrophoresis using a 0.7'i
horizontal agarose gel at 30 V for 16 hr in TAE buffer. The
gel was then stained with EtBr to visualize the R. E.
fragments.

A 2 mm wide trough was cut in front of the

leading edge of the 7.5 Kb fragment* and the trough was
filled with electrophoresis buffer.

The band was then

observed by UV light as it was electroeluted from the gel
into the trough at 200 V.

Every 30 to 40 seconds the fluid

from the trough was recovered* and the trough was refilled
with fresh buffer.

Electrophoresis was then continued until

all the DNA in the band was removed from the gel and was
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recovered in the fluid taken from the trough (Fig. V. 3).
The probe was further purified of contaminating gel
components by ion—exchange chromatography using a nucleic
acids chromatography column (NACS P R E P A C ™ mini-column)
(Bethesda Research Laboratories* MA).

The DNA mas

precipitated in two volumes of cold ethanol at -20 C for 2
hr and then pelleted at 15*000 x g* 15 min* A C.

The pellet

was resuspended in 20 ul TLE.
V. B. 9. Nick Translation of BLV-DNA Probe
The BLV-DNA probe was radiolabelled with a-32P labelled
deoxycytosine triphosphate (dCTP Ca-^^Pl) by nicktranslation using a Nick Translation Kit” (Cooper
Biomedical* PA).

Briefly* 2 ug of BLV-DNA* 5 ul of nick

translation buffer* 1 ul of each of dATP* dTTP and dGTP* 10
ul of dCTP Ca—33rP3 (10 mCi/ml)

(New England Nuclear* MA), 2

ul of DNAase 1/ DNA polymerase I mixture and H^O were added
to make a 50 ul reaction mixture.

The mixture was incubated

at 18 C for 1 hour* and the reaction stopped with 20 mM
EDTA.

The unincorporated isotope was removed from the nick-

translated DNA using gel filtration chromatography using a
MINI—SPIN” column (Cooper Biomedical, PA).

This column

consisted of a pre— hydrated* prepacked column of Sephadex*
G-50.

The nick-translated probe was then dissociated into

single-stranded DNA by the addition of 1/10**' volume of 2 M
NaOH.

The specific activity of the radiolabelled probe was

determined by scintillation counting of the probe using Hz0
as a scintillation medium (Packard Tricarb Scintillation

ea
Counters USA).
V. B. 9. Filter Hybridization
Nitrocellulose filters were prehybridized in
hybridization mixture (103) for 48 hr at 37 C.
Hybridization was carried out by adding 1.5 x ID7 cpm of the
single-strandedt nick translated 33P-BLV DNA cloned probe in
B ml of hybridization buffer.

The filters were wrapped

in SaranR wrap and once in aluminum foil.
incubated for 48 hr at 37 C*

x 2

The filters were

washed for 1 hr in a .high salt

solution <2x SSC and 0.5% sodium dodecyl sulfate (SDS) at 37
C and for 2 hr in a low salt solution (0-lx SSC and 0.5%
SDS) (104) at 45 C.
V. B

10.

Filters were dried at 60 C for 1 hr.

Autoradiography

Filters were exposed at -70 C to Kodak X RP-5 X—Omat
film in the presence of 2 Cronexj Lightning Plus'S
intensifying screens (Dupont( U.S.A.) for 2-5 days.

The

exposed film was then developed using a Kodak X-Omat
Processor (Kodak T U S A ).

V. C. RESULTS

V. C. 1. Purity of T Lymphocyte Preparations
The frequency of T and B lymphocytes in the PBMC and
purified T lymphocyte preparations used for DNA
hybridization analysis can be found in Table V. 1.

The

frequency of T lymphocytes in the PBMC of AL and BLVnegative control animals ranged from 69 to 89%.

The
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frequency of B lymphocytes in the PBMC of these animals
ranged from 15 to 23%.

In the purified T lymphocyte

preparations* frequencies of T lymphocytes ranged from 91 to
97%* and frequencies of B lymphocytes ranged from 0 to 4%.
Based on 1 x 10s cells (quantity of cells iysed for DNA
purification) the absolute number of contaminating B
lymphocytes were estimated for each DNA preparation.
Animals Y 12 and Y 74 were assumed to have no B lymphocytes
in their purified T lymphocyte preparations* whereas*

in the

PBMC of these animals there were 5 x 10* and 13 x 10* B
lymphocytes* respectively.

In the purified T lymphocyte

preparation of animal Y 75* there were 3 x 10* B lymphocytes
f

versus 23 x 10* B lymphocytes found in the PBMC of this
animal.

In the T lymphocyte preparation of animal Y 32*

there were 4 x 10* Blymphocytes versus

27 x 10* B

lymphocytes found in the PBMC of this animal.
V. C. 2. Agarose Gel Electrophoresis
Results of the agarose gel electrophoresis of R. E.
fragments show that test DNA was present in relatively equal
concentrations in each of the lanes of the gel.

Also* the

enzyme Sac 1 effectively digested the DNA's as evidenced by
detection of the highly repetitive DNA sequences (Fig. V. 3)
V. C. 3. DNA Hybridization Analysis
As shown in Figures V. 5 & 6* ^“ P-labeled BLV DNA
hybridized on the 7.5 Kb Sac 1 fragment from the PBMC of all
BLV-positive AL and PL cattle and the FLK-BLV positive
control DNA.

No hybridization was observed to the DNA

fragments from BLV—negative cattle.

DNA from the purified T

lymphocyte preparations of 3 AL animals (Y 74, Y 75, and Y
32) were positive for hybridization on the 7.5 Kb Sac 1
fragment with the BLV-DNA probe.

The quantity of DNA which

hybridized with the probe appeared to be much lower in the
purified T lymphocyte DNA preparations than in the
respective PBMC DNA preparations because the respective
bands on the autoradiographs were much less dense than those
of the PBMC DNA preparations.

Cow Y 74 contained no

detectable B lymphocytes in the purified T lymphocyte
preparation but its DNA gave a positive hybridization signal
with the BLV-DNA probe.

Cow Y 12 which also contained no

detectable B lymphocytes in the purified T lymphocyte
preparation gave negative hybridization results.

V. D. DISCUSSION

The purpose of this study was to determine if bovine T
lymphocytes were targets for BLV infection.

Results from

the experiments reported herein suggest that bovine T
lymphocytes of some AL cattle contain the BLV provirus.

The

BLV provirus was detected in the DNA of PBMC from all AL
animals and also in the DNA of 3 of 4 purified T lymphocyte
preparations from AL animals.

Two of the T lymphocyte

preparations which gave positive hybridization results
contained only small amounts of contaminating B lymphocytes
(3 and 4%).

It has been well documented that the B

lymphocyte is a target for BLV infection (45,108,121).
Therefore,

it is possible that the positive hybridization

results obtained from the DNA of these 2 cel) preparations
were due to the DNA from contaminating BLV-infected B
lymphocytes.

Less than 25% of B lymphocytes from BLV-

infected animal5 have been shown to produce viral particles
or display viral antigens on their cell surfaces after short
term incubation (121,73).

Therefore,

less than 10 x 10s

BLV-infected B lymphocytes were possibly present in the
purified T lymphocyte preparations.

It is possible that

this amount of BLV-infected lymphocyte DNA can give a
hybridization signal because of the sensitivity of the solid
Phase hybridization procedure.

The sensitivity of the solid

phase DNA hybridization assay is such that it can detect 1
proviral copy in 10. (personal communication Dr. James
Casey, National Cancer Institute, Fredrick, tiD).

When

comparisons of the percentage of B lymphocyte DNA in the
purified T lymphocyte preparations and the percentage of B
lymphocyte DNA in the PBMC of the same animals were made
with their respective hybridization signals on the
autoradiographs,

it appeared that the signals generated by

the purified T lymphocyte DNA preparations were greater than
what would be expected if only B lymphocytes contained the
BLV provirus.
One purified T lymphocyte preparation (animal Y 74)
contained no detectable B lymphocytes.

The DNA from this

cell preparation gave positive hybridization results.

It is

possible that a population of slg- B lymphocytes exists in
cattle* but this has not been reported.

The marker used in

this study to enumerate bovine B lymphocytes has been shown
to be highly specific for bovine peripheral blood B
lymphocytes (55*90*85).

The lymphocyte surface marker

profile of this animal appeared normal using flow
microfluorimetry (FMF) (Chapter III).

Monoclonal antibodies

(MAbs) against surface bound IgM (PIg45a> and Rablg-FITC
markers for B lymphocyte enumeration and MAbs against T
lymphocyte surface antigens and PNA receptors for T
lymphocyte enumeration were used in the FMF assays (Chapter
III).
One additional AL animal (Y 12) had no detectable B
lymphocytes in the purified T lymphocyte preparation.
However*

the DNA from this preparation' gave no hybridization

with the BLV—DNA probe.

The DNA of the PBMC from this

animal gave a weaker hybridization signal than the DNA from
other AL animals and this indicated that fewer cells
contained the BLV provirus.

The BLV-infected T lymphocytes

may have been depleted in the “panning* procedure since the
average yield of T lymphocytes from “panning" is 48 % of the
original number of T lymphocytes applied to the “panning"
flask (Refer to Figure VI. 2).

Another possibility is that

not all AL animals have detectable levels of BLV-infected T
lymphocytes.
This study documents the first attempt to assess the
presence of the BLV provirus in highly purified peripheral

blood T lymphocyte populations from BLV-infected AL cattle.
Hybridization studies reported to date using highly specific
BLV-DNA probes and buffy coat preparations or PBMC*
demonstrated that the BLV provirus was present in the
lymphocyte population (75*76).

It was also shown that the

ability to produce C-type viral particles resided with the B
lymphocyte subset (121).

However* definitive studies on

highly purified peripheral blood lymphocyte subsets had not
been reported.

A recent report showed that lymphoblastoid-

like cells derived from two EBL tumors not only had markers
of the T lymphocyte lineage but also contained the BLV
provirus (91).

Therefore,

it appeared that bovine T

lymphocyte population of BLV-infected animals may be
infected with the BLV provirus.
The results of this study suggest that the B lymphocyte
is the major target cell of BLV infection in the AL animal.
After B lymphocytes were depleted from PBMC using "panning"
with anti-bovine Ig* the amount of DNA in the "panned” cell
preparation which hybridized with the 32P BLV—DNA probe was
greatly reduced.

This indicates that a large number of BLV-

infected cells (B lymphocytes) were removed by the "panning”
procedure.

This study also suggests that the BLV provirus

can be detected in the DNA of T lymphocytes of some AL
animals.

It appears that only a small number of these cells

are infected by the virus* as evidenced by the weak
hybridization signal from the purified T lymphocyte DNA
preparations.

Therefore, BLV may infect only a

subpopulation of T lymphocytes in the peripheral blood of AL
animals.

Infection of this cell population may alter

function of these cells and thereby facilitate the
transition from the AL to PL stage of EBL.

Possibly*

infection of the T lymphocytes is a prerequisite for the
progression to the PL state.

In order to address this

hypothesis* purified T lymphocytes from PL animals must be
screened for BLV provirus.

The purification techniques

which were used in this study for T lymphocyte purification
were not applicable to PBMC of PL animals (Refer to Chapter
IV).

This was probablly due to the very low frequencies of

T lymphocytes present in the PBMC preparations.
The question of whether BLV infects cells of the T
lymphocyte lineage is of importance for the use of EBL as a
model for the viral-incuced human adult T cell leukemia
(ATL) associated with human T cell leukemia virus (HTLV I)
(162).

Many aspects of the disease induced by HTLV I

parallel those of EBL (162*121).
chronic.

The disease is typically

Lymphocytosis occurs in some cases as do

immunodefficiencies.

Lymphoma occurs in a small percentage

of infected individuals.

A major difference between ATL and

EBL is that the target cell of HTLV I appears to be the T
lymphocyte and the major target cell of BLV appears to be
the B lymphocyte (162* 121).

The data presented here

indicate that bovine T lymphocytes may also act as targets
for infection by BLV and therefore* this information may
contribute to the BLV model of HTLV— induced leukemogenesis.
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Figure V.4.

Gel Electrophoresis of Sac 1 Restriction Enzyme
Fragments of Lymphocyte DNA.
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Table V. 1 — Frequencies of T and B Lymphocytes
for DNA Hybridization Analysis

Animal
No.

Peripheral Blood
Mononuclear Cells
% T a

B L V (AL)c
Y 74

% B b

Purified
T Lymphocytes
% T

% B

79

13

97

0

Y 75

76

23

91

3

Y 32

69

27

95

4

Y 12

79

5

95

0

R 52

69

20

ND

ND

Y 73

73

22

94

2

BLV

(— )d

aCells positive for fluorescence using PNA-FITC.
^Cells positive for fluorescence using Rablg-FITC.
cBovine leukemia virus positive, aleukemic state.
No detectable antibodies to bovine leukemia virus.

CHAPTER VI: EVALUATION OF THE RESPONSES OF LYMPHOCYTES OF
ALEUKEMIC AND PERSISTENT LYMPHOCYTOTIC CATTLE TO
SELECTED PHYTOMITOGENS

VI- A. INTRODUCTION

Approximately 30% of cattle infected with bovine
leukemia virus (BLV) develop a benign condition referred to
as persistent lymphocytosis (PL)

(10B). The PL state is

characterized as a persistent elevation of primarily
lymphocytes in the peripheral blood (108).

B

Animals with PL

develop clinical lymphosarcoma (LS) more frequently than do
BLV-infected) aleukemic (AL) cattle which have no clinical
signs (51).

Therefore) the transition from the AL to PL

state may be a primary step in the progression of the
disease to the tumor state.
It is unclear what factor(s) mediate the switch from
the AL to the PL stage or allow for the uncontrolled B-cell
lymphocytosis.

A possible factor may be a modulation of a

specific T-helper or suppressor cell population that elicit
soluble factors which help to regulate B lymphocyte
proliferation (81).

However)

little is known about the

immunological and functional properties of lymphocytes of AL
or PL cattle.
It has been demonstrated in other leukomogenic
retroviral infections (human adult T cell leukemia (ATL))
feline leukemia) murine leukemia) avian leukemia)
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that immunosuppression takes place as a result of retroviral
modulation of immune cells (13* 159* 26).

Immunosuppression

may occur as a result of the interaction of BLV with its
target cells.

It has been documented that the B lymphocyte

is a target cell for BLV infection (45*73*76).

It has also

been demonstrated that the T lymphocytes from the peripheral
blood of some AL animals and tumors of some LS animals
contain the BLV provirus (Chapter V f9i).

An increase in

the absolute T lymphocyte numbers in AL animals and an
increase in the absolute number T and B lymphocytes in PL
animals has also been observed (Chapter 111*142).

It is

unclear whether these factors affect T lymphocyte function
in BLV-infected animals.
The mitogenic stimulation of lymphocytes as measured by
uptake of 3H thymidine is used to evaluate inherited and
acquired immunodeficiencies and the effect of the
iiwnunoenhancing or immunosuppressive action of serum factors
(4* 112*157).

This technique can therefore be used as an

indicator of lymphocyte function.

Mitogens such as

phytohemagglutinin (PHA>* Concanavalin A (Con A) and
pokeweed (PWW) have been used tD assess the mitogenic
response of bovine lymphocytes (111*112*132*157).

The PHA

and Con A responsiveness is a property of bovine thymusderived lymphocytes <T lymphocytes)

(111*132) and the PWM

responsiveness is a property of both T and B lymphocytes
because a B lymphocyte mitogen requires the presence of T
lymphocyte soluble factors to obtain a full blastogenic
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response (111,132).
In studies with BLV-infected animals* the lymphocyte
response to PWM and PHA* as indicated by the use of
stimulation index (S.I.), was markedly less for those cells
obtained from animals with PL than for those obtained from
hematologically normal animals (112).

The lymphocytes from

cows with PL that were cultured without phytomitogens
incorporated approximately 5 times more tritiated thymidine
than did lymphocytes from normal animals (112).

It was

also shown that the lymphocyte stimulation of AL animals
appeared to be normal when blastogenesis assays were
conducted using PHA as the mitogen (68).

Another study

suggested that the stimulatory effect of Con A on
lymphocytes of PL- cattle was significantly depressed when
compared to response using normal lymphocytes (157).

These

results suggested that the T lymphocyte population of PL
animals may be functionally affected in the ability to
respond to mitogens.

However*

the depressed stimulation may

have been the result of low numbers of T lymphocytes present
in the lymphocyte preparations of PL cattle used in the in
vitro blastogenesis assays or because stimulation index was
used to assess the responsiveness to mitogens.

These

questions have not been fully considered.
Inhibition of lymphocyte blastogenesis of normal
lymphocytes by sera from cows with LS has been shown but
suppression has not been demonstrated with the sera from PL
or AL cattle (164).

If present*

these serum factors may
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affect immunoregulation.
The purpose of the present investigation was to compare
the response of lymphocytes from AL and PL cattle to
phytomitogens PHA, ConA* and PWM using the in vitro
lymphocyte blastogenesis assay.

The responsiveness of the

cells to mitogens were compared to the T/B lymphocyte ratios
from these animals.

The effect of sera from AL and PL

cattle on lymphocyte blastogenesis of BLV—negative control
cattle was also evaluated to determine if suppressive or
augmenting factors were present.

VI. B.

MATERIALS AND METHODS

VI. B. 1. Animals
A total of 9 cows of at least 3 years of age mere used
in this study.

The animals were examined clinically and

hematologically for symptoms of bovine leukosis* and the BLV
infection status was monitored by detection of serum
antibodies to BLV structural antigens using the double
immunodiffusion assay (33).

Of the 9 animals* 3 were BLV-

negative on repeated tests* 3 were AL and 3 were PL as
determined by the critera of the International Committee of
Bovine Leukosis (2).
VIII* Table VIII.

(For more details refer to Chapter

1.)

VI. B. 2. Isolation of Peripheral Blood Mononuclear
Cel Is
Peripheral blood was collected by Jugular venipuncture
into 20 ml vacutainer tubes containing 20 units/ml of

preservative-free heparin (Sigma Chemical Co.* U.S.A.).

The

heparinized blood was then diluted in an equal volume of
calcium and magnesium free (CMF) Hanks buffer* pH 7.4.
Twenty milliliter aliquots were layered onto equal volumes
of sodium diatrizoate/ficoll

(Histopaque" 1D77* Sigma

Chemical Co.* U.S.A.) in 50 cc conical centrifuge tubes
(CDstar* U.S.A.).

The gradients were centrifuged for 30 min

at 1000 x g at room temperature* and the cells banded at the
Histopaque"— plasma interface were collected and washed twice
in CMF Hanks buffer at 50D x g for ID min at room
temperature.

Viability counts were done using 900 ul of 10%

trypan blue mixed with 100 ul of cells* and the peripheral
blood mononuclear cell

(PBMC) concentration was adjusted to

2 x 10* viable cells/ml in RPMI 1640 medium (GIBC0*
Burlington* Ontario) supplemented with NaHCo3 and
antibiotics (100 units/ml of penicillin and 100 ug/ml of
streptomycin* 5 ug/ml gentamycin).
VI. B. 3. Complete Blood Counts
Blood was collected in tubes containing
ethylenediaminetetraacetic acid as an anticoagulant.

Total

leukocyte counts were determined on an automatic cell
counter and differential counts were performed.
VI. B. 4. Enumeration of T/B Lymphocyte Ratios
Aliquots of PBMC which were isolated for the lymphocyte
blastogenesis assays were stained for B and T lymphocyte
enumeration using the following procedure.

To identify B

lymphocytes* 3 x 10* PBMC were mixed with 10D ul (G.74mg/ml)
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of fluorescein— conjugated Ftab'J^. fragments of rabbit antibovine IgG, H & L chains specific <Cappel Labs,
Cochranvi1le, PA).

To identify T lymphocytes, 3 x 10fc PBMC

were mixed with 10 ul B26a (1 mg/ml, bovine pan T cell
monoclonal antibody which recognizes the sheep RBC receptor
on T lymphocytes)

(courtesy of Dr. William Davis, Washington

State University, Pullman* WA>.

The PBMC were incubated at

A C for 30 min in the dark, then washed twice in 1 ml
aliquots of phosphate buffered saline (PBS) pH 7.4 with
0.05% NaN3 (PBS NaN3 ) to prevent antibody capping.

PBMC

pretreated with B26a were stained with 100 ul (1 mg/ml) of
fluorescein-conjugated goat anti-murine IgG, IgA, IgM
mixture (goat anti-mouse-FITC) (Cappel Labs., Cochranvi1le,
PA),

incubated and washed as described above.

then fixed in 0.551 formalin in PBS-NalM3 .

The PBMC were

An aliquot of PBMC

was also stained with goat anti—mouse FITC as a control.
The method used for the detection of fluorescencepositive celIs was fluorescence microscopy.

Positive cells

were enumerated by counting 200 cells at 1000 x
magnification with the aid of a fluorescence microscope
equipped for phase contrast and incident UV light
illumination (Leitz, Germany).

The T/B ratio was then

determined by dividing the average of the percent T
lymphocytes by the average of the percent B lymphocytes in
the peripheral blood of each animal.
VI. B. 5. Serum Preparation
Twenty ml of blood was collected from each animal into

lOD

vacutainer tubes at sane tine blood was removed for
blastogenesis assays.

The blood was allowed to clot at room

temperature for one hour, and centrifuged at 1000 x g for 15
min.

The harvested serum was filter sterilized by

ultrafiltration with a 0.45 um disposable syringe filter
(AcrodiscR, Gelman, U.S.A.).

One half of the serum was heat

inactivated at 56 C for 30 min* and the remaining serum was
kept at 25 C until used.

The sera (both heat inactivated

and fresh) were then diluted in RPMI 1640 medium to a final
concentration of 40% which was mixed in the lymphocyte
blastogenesis test with an egual volume of cell suspension
to yield 20% final concentration.

Heat inactivated fetal

calf serum (FCS) and heat inactivated sera from BLV-negative
cows were diluted to 40% with RPMI 1640 medium and used as
serum controls.
VI. B. 6. Preparation of Mitogens
Suboptimal and optimal concentrations of Con A* PHA,
and PWM as determined by pre-testing on the PBMC of BLVnegative, clinically normal animals were prepared in RPMI
1640 medium.
VI. B. 7. Lymphocyte Blastogenesis Assay
The lymphocyte blastogenesis assay was performed as
previously described (143).

Briefly, the test was conducted

in flat-bottom, 96-well,

tissue culture plates with 2 x 10=

viable PBMC cells/well.

Medium in the wells contained a

final concentration'of 20% (v/v) of serum.

Each animal's

lymphocytes were tested with the following sera added: fresh

ioi
autologous sera, heat-inactivated autologous sera* heatinactivated control BLV-negative sera* and FCS (Fig. VI.2.).
The total well content was 0.2 ml* to which 1 of the
following had been added (final concentrations): Con A* 5
and 30 ug/ml; PHA* 2 and 5 ug/ml; and PWM* 0.05 and 0.2
ug/ml. The lower concentrations represented the subDptimal*
and the higher concentrations* the optimal doses of mitogens
to stimulate lymphocytes from a majority of clinically
normal cows.

For each animal's cells* there were 6 control

wells used with PBMC without addition of the mitogens* and 3
wells for each mitogen concentration and the given serum
addition.

(Refer to Figure VI.1 for flow diagram.)

To test for the presence of blastogenesis augmenting or
suppressive factors in the serum of BLV-infected animals*
serum was obtained from 3 AL and 3 PL animals and 2 BLVnegative control animals at 2 intervals 30 days apart and
processed as above then applied to lymphocytes of BLVnegative animals.

Heat— inactivation was used to determine

if possible augmenting or suppressive factors present in the
serum were heat stable.
The PBMC were incubated at 37 C in 5Z CCL. for 3 days*
labeled with [3HDthymidine (1 uCi/well)* and incubated for
an additional A hours.

The PBMC were harvested onto Skatron

filter mats* using a multiple-well cell harvester (Skatron*
Norway).

After treating each sample with Concifluor”

toluene scintillation cocktail (Fisher Scientific* U.S.A.)*
the radioactivity or counts per minute (cpm) was determined
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using a scintillation counter (Packard TriCarb, Union
Carbide* U.S.A.).
VI. B. 7.Statistical Evaluations
Statistical evaluations were performed on log
transformed data using standard programs of the Prophet
Computer System (U.S. Dept, of Health and Human Resources*
Bethesda* HD.).

To test the hypothesis of homogeneity of

variance the Bartlett's test was used (14).

A two-tailed T—

test using unpooled variances was performed on all data
(136* 14).

The nearest P value was calculated.

Data were

considered significant at a level of P < 0.05.

VI. C. RESULTS
The results of blastogenesis assays were expressed as
the log of the stimulation index (S.I. = cpm of mitogenstimulated PBMC divided by cpm of unstimulated PBMC grown in
the presence of the same serum)

(Fig. VI. 3) and as the log

of delta counts per minute (cpm of mitogen—stimulated PBMC
minus cpm of unstimulated PBMC grown in the presence of the
same serum ) (Fig. VI 4.).

The responses of lymphocytes

from the animals used in blastogenesis assays were
determined using FCS as the serum source because of the
variability encountered when autologus and homologus sera
were used.
There were no significant differences noted between the
responsiveness of PBMC from AL and BLV-negative animals when
SI was used to measure the response to Con A* PHA* and PWM
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(Table VI. 1).

The PBMC of PL animals appeared to have

a

significant decrease in the blastogenic response to Con A (p
< 0.01), PHA (p < 0.01) and PWM (p < D.G2) when SI was used
as a measure of the mitogenic response.

It was also

observed that the spontaneous blastogenesis (PBMC cultured
with no mitogen) was significantly higher for the BLVinfected anixals when compared to that of BLV-negative
animals (Table VI. 2).
When delta cpms were used as a measure of the mitogenic
responsiveness of lymphocytes from AL and PL animals*

it was

found that there were no significant differences in the
responses to any of the mitogens when compared to the
mitogenic response of lymphocytes from BLV—negative animals
(Table VI. 2).
T/B lymphocyte ratios from BLV-negative control* AL and
PL animals are shown in Table VI. 3.

The T/B ratios from PL

animals were lower than those from either AL
control animals.

or BLV-negative

There were fewer T and more B

lymphocytes

in the PBMC preparations used in the blastogenesis assay for
these animals (B 10, Y 11* Y 13). There was
the T/B ratio of

an increase in

AL animals when compared to PL or BLV-

negative animals..

There were fewer B and more T lymphocytes

in the PBMC preparations used in the assay.

When lymphocyte

responses to phytomitogens were compared to T/B ratios using
linear regression analysis,

it was found that there was no

correlation between
The presence of possible suppressive or augmentative

IDA

factors for blastogenesis in the sera of BLV-infected
animals was assessed by the addition of these sera to PBMC
from BLV—negative control animals in the presence of
mitogens.

The data was expressed as corrected counts per

minute (cpm of mitogen—stimulated BLV-negative PBMC in the
presence of BLV-infected serum minus cpm of mitogenstimulated BLV-negative PBMC in the presence of BLV-negative
serum) (Figure VI. 5).

The sera from AL and PL animals

augmented the mitogenic response of lymphocytes to optimal
concentrations of Con Ai PHA and PWM in comparison to the
reponses observed BLV-negative control sera.

No

augmentation was observed in cultures without mitogen. The
blastogenic response of the lymphocytes to all mitogens was
greater in sera from PL animals than sera from AL.

The

blastogenesis augmenting factor was active on both T and B
lymphocytes and was heat stable at 56 C for 30 min.

VI. D. DISCUSSION

The stimulatory effect of optimal concentrations of PHA*
Con A and PWM on the PBMC from BLV-negative control animals
could be demonstrated clearly in the experiments reported
herein.

The values obtained in lymphocyte blastogenesis

studies with optimal concentrations of mitogens were used in
this study to assess the blastogenic responsiveness of
lymphocytes.

The use of suboptimal concentrations of
i
mitogens gave no different information on the response of
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lymphocytes to various mitogens. These data are not
presented.
When SI was used to measure the mitogenie
responsiveness of lymphocytes from BLV— infected animals*
there appeared to be a false assessment of the response due
to the high spontaneous blastogenesis observed in the
unstimulated PBMC cultures.

SI was calculated by dividing

the cpm obtained from mitogen—stimulated PBMC by the cpm of
unstimulated PBMC.

If spontaneous blastogenesis was high

and the response to mitogens was within the normal range
then the SI was low.

Therefore* the PL animals which had

high spontaneous blastogenesis had low SI.
The observations that lymphocytes from PL animals
undergo high levels of spontaneous blastogenesis and have
low SI are in agreement with previous reports (112*143).
This information led to the original conclusion that
lymphocytes from PL animals have depressed responses to
mitogenie stimulation. This does not appear to be a correct
conclusion as discussed below.

The observation that the

lymphocytes of AL animals undergo high levels of spontaneous
blastogenesis has not been previously reported.
When delta counts per minute were used to measure the
mitogenie responsiveness of lymphocytes from AL and PL
animals* no significant difference was noted when compared
to the response observed for the lymphocytes of BLV-negative
animals.

This suggested that the lymphocytes of BLV/

infected AL and PL animals are capable of normal mitogenie

106

response to both T and £ lymphocyte mitogens.
It has been observed that there is an increase in the
absolute number of T lymphocytes in the peripheral blood of
AL animals (Chapter 111).

It was shown in this study« that

T/B ratios were higher in AL animals than either PL or BLVnegative animals.

More lymphocytes with T lymphocyte

markers were present in the PBMC preparations of AL animals
used for the blastogenesis assays.

This increase in T

lymphocyte numbers did not appear to affect the overall
response to optimal concentrations of the mitogens used in
this study.

It has been shown that the response of

lymphocytes to Con A is a property of the T lymphocyte
population but is dependent on accessory cells (monocytes)
(B2*86).

Therefore* even though T lymphocyte numbers were

more numerous in the cultures from AL animals used for the
mitogenie studies*

the limiting factor may have been the

concentration of monocytes in the culture.
It was also observed that as the T/B ratios decreased
(PBMC of PL animals)* there was no significant increase or
decrease in the ability of the cultured cells to respond to
mitogens.

Even though there were more B lymphocytes in the

cultures of PL animals used in the blastogenesis assay* the
response to PVNi was not elevated.

Responsiveness to PWM is

predominantly a property of B lymphocytes (111*112).

The

ability of B lymphocytes to respond to PWM is T lymphocyte
(T— helper) dependent (112*111).

Even though there was an
/

increase in the number of lymphocytes with B lymphocyte
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markers in the cultures used for mitogenie studies* no
increase in the response was observed because the
concentration of T— helper cells might have been the limiting
factorThe increase of peripheral blood T lymphocytes in AL
animals and Blymphocytes in PL animals mag be the result of
antigen-induced expansion of T and B lgmphocgte clones*
respectivelg.

These cells mag also be responding to

infection bg BLV (Chapter V* 91)-

The high spontaneous

blastogenesis as measured bg the synthesis of DNA indicates
that cells in the cultures from AL and PL animals were
undergoing high levels of mitosis.

These stimulated cell

populations might have been refractory to further mitogenie
stimulation therefore* no increase in the response to
mitogens was observed.

It was concluded that the increase in

the relative numbers of T and B lymphocytes in the cultures
used for blastogenesis assays did not affect the response to
selected phytomitogens.

Therefore* the lymphocytes of AL

and PL animals were considered as responsive to mitogenie
stimulation as lymphocytes from BLV-negative* clinically
normal animals
Sera from AL and PL animals contained a heat—stable
blastogen'esis-augmenting factor(s).

This factor enhanced

the mitogenie response of lymphocytes from BLV-negative
animals for Con A* PHA and PWM.

No augmentation was

observed with BLV-negative control sera nor was
/

blastogenesis augmentation observed in the absence of

10B

mitogenie stimulation.

Therefore*

it was assumed that this

factor was a comitogenic serum factor or one that works in
the presence of mitogens or exhibits its activity on mitogen
and /or antigen—activated cells.

Sera from PL animals gave

a higher degree of stimulation than did sera from AL
animals.
Since the augmenting factor enhanced the blastogenic
activity of all three phytomitogens*

it was assumed that the

effect was on both B and T lymphocytes.
heat stable.

This factor was

No further characterization of the serum

factor was attempted in this study.
Uhen HTLV— III— infected T lymphocytes are stimulated to
divide by antigen activation* the viral genome is also
activated (105).

There is then production of the trans-

activation of transcription <tat) viral gene product.

This

protein enhances the expression of not only the proviral
genes but also the genes for interleukin—2 and its receptor
(105).
divide.

The infected cells are then further activated to
This tat enhancement of antigen— driven lymphocyte

blastogenesis also appears to occur in the other HTLVs (I
and II)

(105).

BLV is closely related to HTLV I and II and
>
has been found to contain a tat gene (128*131).
The co

rnitog enic factor found iii the sera of BLV— infected animals
may be the tat protein.

The enhancement of mitosis was only

apparent when PBMC of BLV-infected animals are cultured in
the presence of mitogens and sera from BLV— infected animals.
The mitogenie activation of lymphocytes appeared to be

10?
necessary before this protein bias able to enhance the
blastogenic response.

An increase in concentration of this

factor in the sera of PL animals may be responsible for
maintenance of the PL state.
The T and B lymphocytes of BLV-infected animals used in
this study

appeared to be responsive to the selected

phytomitogens.

Responsiveness to mitogens is used as an

indicator of functional competence of lymphocytes
(4,111*132).

This study indicates that at least a portion

of lymphocytes from AL and PL animals respond to mitogenie
stimulation at least to a level comparable to that of
lymphocytes from BLV-negative,

clinically normal animals.

The blastogenenesis augmenting factor present in the sera of
PL animals may be important in maintaining the PL stage of
EBL.
The observation that BLV-infected animals have a
blastogenesis augmenting factor present in their sera is
important for the establishment of BLV-induced enzootic
bovine leukosis as a model for HTLV I induced ATL.
lymphocytosis occurs in some cases of ATL (162).

A T— cell
The tat

protein appears to be responsible for the rapid
proliferation of antigen-activated lymphocytes in this
disease (105).

If the tat protein of BLV is found to be

responsible for the B-cell lymphocytosis observed in PL
animals, BLV-induced persistent lymphocytosis in cattle may
be used as an animal model for HTLV— induced ATL.
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Table VI. 1. Statistical Analysis of Lymphocyte Blastogenesis
of Lymphocytes from Bovine Leukemia Virus
Infected Cattle Using Stimulation Index*

**
BLV
Status
BLV (-) Vs
BLV (AL)

BLV (-) vs
BLV (PL)

Mitogen

T Value

Con A

1.391

16

N.S.-^

PfiA

1.495

16

N.S.

EWM

0.631

16

N.S.

Con A

2.654

16

0.01

FHA

2.257

16

0.01

PWM

3.985

16

0.02

Degrees of
Freedom

P Value

*

Stimulation Index = cpns of mitogen treated cultures divided
by cpns of cultures with no mitogen.
**

BLV Status indicates: BLV (-) = Cattle negative for BLV
antibodies. BLV(AL) = Cattle positive for BLV antibodies but
have no clinical signs. BLV (PL) = Cattle positive for BLV
antibodies and have persistent lymphocytosis.

+
Optimal Concentrations.

Not significant at the level of p = 0.05.
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Table VI. 2. Statistical Analysis of Lymphocyte Blastogenesis
of Lymphocytes from Bovine Leukania Virus
A
Infected Cattle Using Corrected Counts per Minute
**
BLV
Status

BLV (-) vs
BLV (AL)

+
Mitogen
■

T Value

Degrees of
Freedom

p Value

None

2.015

16

0.05

Con A

1.629

16

N.S.

PHA

1.894

16

N.S.

PWM

1.858

16

N.S.

None

2.677

Con A

0.3512

16

N.S.

PHA

0.3522

16

N.S.

PVM

0.1246

16

N.S.

I. I.

BLV (-) vs
BLV (PL)

0.02

Corrected counts per minute = cpns of mitogen treated cultures
minus cpns of cultures with no mitogen treatment.
**

BLV Status indicates: BLV (-) = Cattle negative for BLV
antibodies. BLV(AL) = Cattle positive for BLV antibodies
but have no clinical signs, BLV (PL) = Cattle positive
for BLV antibodies and have persistent lymphocytosis.

+
Optimal concentrations.

++
Not significant at the level of p = 0.05.
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Table VI. 3. T / B Lymphocyte Ratios of Bovine
Leukemia Virus-Infected Cattle

Animal
Numbers

R 52
R 54
Y 73

.BLV

Status

mm
-

T /B a
Ratio

1.9
2.0
2.0

Y 32
Y 74
Y 75

AL
AL
AL

3.2
5.1
3.3

B 10
Y 11
Y 13

PL
PL
PL

0.5
0.8
0.7

T/B ratio = %T lymphocytes in peripheral blood
divided by the % B lymphocytes in the peripheral
blood.

CHAPTER VIis SUMMARY

The aim of the investigations reported herein was to
obtain a better understanding of the numbers and function of
bovine T lymphocytes in bovine leukemia virus (BLV) infected
cattle in the aleukemic (AL) and persistent lymphocytotic
(PL) stages of enzootic bovine leukosis.
Highly specific monoclonal antibodies that distinguish
bovine T and B lymphocytes and flow microfluorimetry (FACS
analysis) were used to determine the absolute number of B
and T lymphocytes in the peripheral blood of ELV-infected
cattle.

The peripheral blood lymphocyte populations from A

AL and 4 PL cattle appeared to be increased when compared to
that of 4 BLV negative control animals.

The increase in the

lymphocyte population in the AL animals was due to an
increase in T lymphocytes but not B lymphocytes* whereas*

in

the PL animals the increase appeared to be due to an
increase in both T and B lymphocyte populations.

This

information indicates that there is an alteration in the
lymphocyte populations of BLV-infected cattle.
The PL animals showed a significantly higher number of
surface immunoglobulin positive cells (slg"’') than did the AL
animals.

The majority of these cells had IgM on their cell

surfaces* which is typical for virgin (res'ting)*
intermediate or memory B lymphocytes. Therefore*

it appears

that these cells have been induced to proliferate but not to
differentiate into antibody secreting (plasma)
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cells because plasma cells typically do not have surface
bound IgM as do intermediate mature (activated) B
lymphocytes and are rarely found in the peripheral blood.
This observation indicates that the increase in the numbers
of lymphocytes in the peripheral blood of PL animals is not
totally an antigen driven event.

It is possible that the

uncontrolled lymphocytosis is at least in part due to the
activity of a trans activational transcriptional protein
(tat protein)

(a product of the BLV genome).

It was shown

in this study that there is a comitogenic blastogenesis
augmenting factor in the sera of all AL and PL animals
tested.

This factor may be responsible for the further

proliteration of antigen—activated lymphocytes.

It has been

observed that antigen-activated HTLV III virus infected
cells are further induced to proliferate as a result of the
tat protein.
PL animal 632 had an elevated lymphocyte count (72 x
lCP/mm3 of whole blood) and contained a subpopulation of
lymphocytes that appeared to stain for markers of both
bovine B and T lymphocytes.
mere immature.

This suggested that these cells

It has been observed that animals with LS

contain immature lymphocytes circulating in the peripheral
blood.

Perhaps this is the BLV— infected cell population.

We were unable to guantitate the number of T lymphocytes in
this animal using cell surface markers. The lymphocytes of
this animal stained much more intensely with the anti-bovine
Igli monoclonal antibody than lymphocytes from the other PL
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animals tested.

This suggests that there is modulation of

the expression of this immunoglobulin marker in animal 632.
Perhaps the gene that codes for cell surface bound IgM is
enhanced in its expression in PL animals as a response of
the tat protein effect on lymphocytes in the peripheral
blood.
Bovine T lymphocytes were purified from the peripheral
blood of BLV-infected* AL cattle using immuno-affinity
depletion <"panning") with anti-bovine immunoglobulin-coated
flasks.

Large yields of highly purified T lymphocyte

preparations (95-100X T lymphocytes and 0-35C contamination
with B lymphocytes) were obtained from BLV-negative and AL*
but not PL animals by the use of this technique.

This

purification technique was easy to perform* required minimal
amounts of reagents and gave higher yields of purified T
lymphocytes than any
technique.

other currently available purification

It was then possible to assess the presence of

BLV provirus in highly purified T lymphocyte populations of
AL animals.
A 7.5 kilobase fragment of the original BLV— provirus
probe (EcoRl fragment of the FLK-BLV DNA ligated into PUC-S
vector plasmid) was purified by Sac 1 restriction enzyme
digestion* agarDse gel electrophoresis and subsequent
fragment electroelution.

The presence of BLV provirus was

then demonstrated in the DNA of the peripheral blood
mononuclear cells of

all AL animals tested and 3 of the 4

purified T lymphocyte preparations using DNA hybridization
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techniques with the highly specific radiolabelled (3=P) BLVDNA probe.

This study documents the first attempt to assess

the presence of the BLV provirus in highly purified
peripheral blood T lymphocytes from BLV— infected* AL cattle.
These experiments shouted that bovine T lymphocytes are
possible targets of BLV infection.

The significance of this

finding is that infection of T lymphocytes or a specific
subpopulation of T lymphocytes may lead to modulation of
this cell population and may facilitate the progression of
the disease to the PL and ultimately the tumor state.
This study also confirmed that the B lymphocyte is the
major target of BLV infection.

As these cells were depleted

from the PBMC by "panning", the hybridization signal that
was obtained from purified DNA of the "panned" cells was
much less dense than the signal obtained from the PBMC
preparation.
The lymphocyte blastogenesis assay was used as an
indicator of the functional ability of lymphocytes of AL and
PL animals to respond to mitogenie stimuli.

It appeared,

that the responsiveness of lymphocytes from AL and PL
animals to Con A, PHA, and PWM mitogens was comparable to
that of lymphocytes from BLV-negative animals when delta
cpms were used as measurement of mitogenic— induced
blastogenesis.

This indicated that the infection of some

cells of the lymphocyte population does not appear to alter
the overall response of the lymphocytes to mitogenie
stimuli.
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High levels of spontaneous blastogenesis in the absence
of mitogenie stimulation was observed for lymphocyte
preparations of both AL and PL animals.
proliferation of lymphocytes is unclear.

The reason for this
Sera from AL and

PL animals was found to contain a blastogenesis—augmenting
factor(s) when added to lymphocytes from BLV-negative
control animals in the presence of Con A* PHA and PWM.
Therefore*

it appeared that the effect of augmentation was

on B and T lymphocytes.
tat protein.

Perhaps this serum factor is the

The PL animals appeared to have more of this

factor or a more active form of this factor in their sera
than the AL animals.

The PL animals also had higher levels

of spontaneous blastogenesis and higher rates of lymphocyte
proliferation in vivo as Judged by peripheral blood
lymphocytes counts.

The presence of the blastogenesis-

augmenting factor(s) in tne serum of BLV— infected animals
may facilitate the transition from AL to PL phase of EBL and
/or is at least partly responsible for maintenance of the PL
phase of EBL.

CHAPTER VIIis APPENDIX

The animals used in this project mere cows of various
breeds between the ages of 3 and 5 years old (Table VIII.
i>.

They were purchased from sale barns in southern

Louisiana and maintained at the Veterinary Medicine Farm*
Lousiana State University Agricultural Center* Louisiana
State University* School of Veterinary Medicine* Baton
Rouge* Louisiana for at least 3 months before being used in
the project.
lactating.

The animals were neither pregnant* nor
They were judged healthy on physical exam by the

staff veterinarian.

All BLV positive animals were naturally

infected* therefore*

it was not known when infection

originally occurred.

It was not known when persistent

lymphocytosis developed.
Peripheral blood was collected from all test animals at
monthly intervals prior to and during the project.

Serum

was harvested* and the agar gel immunodiffusion test (AG2D)
was performed for the detection of antibodies to BLV
antigens. Total WBC and differiential counts were performed
at monthly intervals to establish the BLV status (AL or PL).
Animals with detectable serum antibodies to BLV antigens but
no clinical signs of disease were considered to be aleukemic
animals (AL).

Animals with detectable serum antibodies to

BLV antigens and a persistent elevation of peripheral blood
lymphocytes (> 7.5 x lCPcelIs/mm3 whole blood over a three
month period) were considered persistent lymphocytotic
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124artimale <PL) (2).

Animals with no detectable antibodies to

BLV antigens on repeated testing were BLV-negative animals.
These BLV negative animals were used as control animals in
all studies.

All animals were also palpated for the

presence of tumors.

No tumors were observed in any of the

test animals.
Animals were screened for Brucellosis and Anaplasmosis
and found negative.
diarrhea virus*

They were also vaccinated for bovine

infectious rhinotracheitis virus and

parainfluenza virus type III by the Louisiana State
University School of Veterinary Medicine clinical staff.
The presence of antibodies to bovine lymphotrophic
retroviruses* bovine syncytial virus (BSV) and bovine visnalike virus (BVV) was also evaluated.

Antibodies to these

viruses were detected by the use of indirect
immunofluoresence test assays utilizing bovine fetal spleen
cells infected with either BSV or BVV (Table VIII.

1).
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Table VIII. 1. Assessment of Viral Infection in Animals
Used for Molecular Studies of Bovine
T Lymphocytes

Animal
Number

Breed

Antibodies
BLV+

BSV**
+

R
R
R
Y

52
54
56
73

Holstein
Holstein
Holstein ,
Jersey

Y
Y
Y
Y

12
32
74
75

Holstein
Holstein
Jersey
Jersey

+
+
+
+

(AL)
(AL)
(AL)
(AL)

B
Y
Y
Y

10
11
13
632

Hereford
Holstein
Holstein
Holstein

+
+
+
+

(PL)
(PL)
(PL)
(PL)

bvvh

+

+

-

-

-

*

-

—

—

—

_

+
-

—
+
+
—

-

+
—

—

+
+

-f

BLV antibodies determined by the use of agar gel
iimtunodiffusion. BLV status determined by clinical
signs.
BLV (-) - Animals with no detectable BLV antibodies
BLV (+)AL - Animals with detectable antibodies to
BLV antigens but no clinical signs of disease
BLV (-f)PL - Animals with detectable BLV antibodies
and exhibit persitent lymphocytosis.
++BSV - Bovine syncytial, virus
I||
BVV - Bovine visna-like virus
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